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Abstract 
The regulation of transcription is an important cellular function because it is the first step 
in gene regulation. In Saccharomyces cerevisiae, two protein complexes, SAGA and NuA4, act 
as regulators of transcription. A common protein shared between these two complexes, called 
Tra1, regulates transcriptional activation through its interaction with gene specific transcriptional 
activators. Tra1 is a member of the PIKK family of proteins, which are characterized by FAT, 
PI3K and FATC domains. The FATC domain encompasses the terminal 33-35 residues of the 
protein. Two mutations within the FATC domain, tra1-L3733A and tra1-F3744A, result in slow 
growth under stress conditions. Partially dominant mutations in the gene encoding Tti2, a 421 
residues component of the TTT chaperone complex, suppressed these phenotypes. My goal was 
to further characterize the role of the FATC domain of Tra1 by determining which 
residues are important for function, and characterize how these relate to the TRA1-TTI2 
interaction. I created alleles of tra1 which convert the terminal residue to serine (tra1-F3744S) 
or arginine (tra1-F3744R), an allele with the two terminal residues inverted (tra1-WF-FW), and 
alleles which resulted in deletions of one or two residues (tra1-Δ1and tra1-Δ2). tra1-WF-FW 
supported cell viability, whereas tra1-F3744S supported cell viability in the presence of the tti2-
F328S suppressor. Slow growth at 37°C resulting from Tra1-WF-FW was also suppressed by 
tti2. Tra1-F3744S grew slowly at 37°C and on 6% ethanol in the presence of the suppressor. 
tra1-F3744R, tra1-Δ1, and tra1-Δ2 would not support viability in the presence or absence of the 
suppressor.  
To better understand the structure and function of Tti2, truncation mutations were created 
to identify essential regions of Tti2. These truncation mutations were assessed by analyzing cell 
viability, protein expression levels, and interaction with Tti1 and Tel2, two other members of the 
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TTT complex. Only Tti2-53-421 (containing residues 53-421) supported viability and retained its 
ability to interact with Tel2 and Tti1 at near wildtype levels. Tti2-53-238 and Tti2-1-238 interact 
with Tel2 but do not support viability. All of the other mutations did not support viability and 
showed minimal binding affinity to Tti1 and Tel2.  
A terminal mutation of another PIKK family member, Mec1 (mec1-W2368A) also results 
in slow growth at 37°C. Interestingly, the tti2-F328S suppressor does not suppress the mec1-
W2368A phenotype. Using bioinformatics approaches, I identified rpn3-L140P, encoding a 
component of the proteasomal cap, as a suppressor of mec1-W2368A.  
Keywords: Tra1, TRRAP, Tti2, Mec1, ATR, Rpn3, SAGA, NuA4, ASTRA, yeast, genetics, 
transcription.  
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Chapter 1: Introduction 
1. Prelude 
PIKKs are a family of proteins involved with cell transcription regulation, DNA repair, and 
nutrient-signalling in eukaryotic cells. The FATC domain of the PIKK protein family has been a 
subject of interest for many years because it is thought to play a role in the kinase activity of 
PIKK protein function. Interestingly, an essential PIKK, known as Tra1 in yeast, does not show 
kinase activity; however, its FATC domain remains an important region of the protein. Tra1 is a 
3744 residue protein and member of essential acetyltransferase complexes including SAGA and 
NuA4. Both SAGA and NuA4 function in transcriptional activation of genes under stress 
conditions. Previous studies examined the effect of altering the FATC domain of Tra1, revealing 
that cells containing mutations to the FATC domain display slow growth under stress conditions 
or are inviable. These Tra1 FATC domain mutations include a substitution of the terminal 
phenylalanine to an alanine (tra1-F3744A), a leucine to an alanine (tra1-L3733A), and an 
addition of glycine to the C-terminus (tral-G3745). Interestingly, a mutation in Tti2, tti2-F328S, 
rescues the slow growth phenotypes of tra1-F3744A and tra1-L3733A (tra1-G3745 is inviable). 
Tti2 is implicated in the proper folding of proteins since it is a component of the TTT complex, 
which associates with HSP 90, and R2TP/prefoldin complex. This led to the hypothesis that one 
role of the FATC domain is for proper folding of Tra1. Notably, Tti2 and Tra1 are both 
components of a group of associated proteins named ASTRA. The Brandl lab is interested in 
trying to elucidate the function of Tra1. The goal of my thesis is to further characterize the 
role of the FATC domain of Tra1 by determining which residues are important for 
function, and characterize how these relate to the TRA1-TTI2 interaction. 
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My introductory chapter covers topics central to Tra1 and its binding partners. These areas 
include: (1) an overview of transcription activation and chromatin remodelling, (2) the PIKK 
protein family, particularly their general structure and cellular function, (3) Tra1-containing 
protein complexes and their functions, (4) a summary of the current knowledge of the role of 
Tra1 determined by mutational studies, and (5) the role of Tti2 in the cell including its 
suppression of tra1 alleles. Mec1, another PIKK protein harbouring kinase activity, is also 
discussed in my introduction as experiments on Mec1 can be used to validate and complement 
findings in Tra1. 
2. Transcriptional Activation and Chromatin Remodelling  
Transcription is the first step for protein expression within the cell. Efficient transcription 
activation is necessary for the cell to produce proteins in response to cell growth, differentiation 
and environmental change. The first step in transcription is the formation of the preinitiation 
complex (PIC) at the promoter (Wandelt and Grummt, 1983). PIC assembly involves localizing 
transcription factors to the target promoter. These transcription factors include TFIIA, TFIIB, 
TFIID, TFIIE, TFIIF, and TFIIH, which are assisted with their localization to the promoter by 
TATA binding proteins (TBP) (Ranish et al., 1999; Reinberg and Roeder, 1987; Flores and 
Reinberg, 1992). TBP, along with TFIID, TFIIA and TFIIB, bind DNA at the promoter region 
(Reinberg and Roeder, 1987; Ranish et al., 1999). TBP, TFIIB and TFIIF are necessary for 
recruiting RNAPII (RNA polymerase II) to the promoter (Killeen et al., 1992). TFIIE and TFIIH 
(one component of which is a helicase) function to separate and stabilize the DNA strands 
(Holstege et al., 1996). This separation and stabilization is important for future steps in 
transcription including promoter clearance and RNAPII elongation (Maxon et al., 1994; 
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Holstege et al., 1996). The nucleosomes surrounding the gene must be altered to allow these 
factors access to DNA. Histone acetyltransferases play a part in this process (Mizzen et al., 
1996). 
Chromatin remodelling is the name given to the process of altering nucleosomes. A 
nucleosome consists of DNA encircling a histone octamer, composed of two molecules of each 
of histone H2A, H2B, H3, and H4, approximately twice, (Luger et al., 1997). In addition to 
transcription regulation, chromatin remodelling is involved in processes such as DNA repair, 
DNA replication and chromosome segregation (reviewed by Clapier and Cairns, 2009). There 
are two principal methods of gaining access to genes enveloped in nucleosomes. The first is by 
moving, removing, or exchanging histones in an effort to change the nucleosome structure in an 
ATP dependent manner (Clark et al., 1992; Adam et al., 2001). An example of histone exchange 
would be switching a histone H2A particle for a histone Htz1 variant at the transcriptional start 
site for RNA PolII recruitment (Adam et al., 2001). The second is through post-translational 
modifications, such as acetylation or methylation, which is thought to elicit a “histone code” 
(Strahl and Allis, 2000; Noma et al., 2001). These modifications can disrupt the interaction 
between DNA and the histone allowing access of other transcription factors to the promoter, as 
well as recruiting cofactors to the promoter that specifically recognize the modified histones 
(Strahl and Allis, 2000; Noma et al., 2001). Methylation can also repress transcription by 
condensing the chromatin (Strahl and Allis, 2000; Rea et al., 2000). The complexes with which 
Tra1 associates contain histone acetyltransferase activity and in the case of SAGA also 
deubiquitylation (Rodríguez-Navarro, 2009). Its role in chromatin modification complexes is one 
reason that Tra1/TRRAP is an interesting target for drug therapy.  
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3. PIKK Protein Family 
The phosphoinositide-3-kinase related kinase (PIKK) family of proteins function as kinases 
within various cell signalling pathways (reviewed by Keith and Schreiber, 1995). These PIKK 
proteins include Tel1 (yeast)/ATM (human), Mec1/ATR, DNA-PKcs (human), SMG-1 (human), 
Tra1/TRRAP, and Tor/mTOR (Keith and Schreiber, 1995). The pathways which involve PIKKs 
are largely those required for stress response. Mec1/ATR, Tel1/ATM and DNA-PKcs are 
implicated in the pathways related to DNA damage, such as single stranded gaps and double 
stranded breaks (Weinert et al., 1994; Jackson, 1996). SMG-1 plays a role in mRNA nonsense-
mediated decay and Tor/mTOR is required for nutrient-dependent signalling (Yamashita et al., 
2001; Barbet et al., 1996).  
The general structure of PIKKs includes five domains: a HEAT domain, a FAT domain, an 
FRB domain, a PI3K domain, and a FATC domain (Figure 1) (Knutson and Hahn, 2011). The 
HEAT (Huntington, Elongation factor 3, A subunit of protein phosphatase 2A and Tor1) domain 
consists of multiple HEAT repeats strung together at the N-terminus of the protein (Brewerton et 
al., 2004; Perry and Kleckner, 2003). These HEAT repeats are a known motif for protein-protein 
interactions (Ruediger et al., 1994). The FAT (FRAP, ATM, TRRAP) domain also consists of 
HEAT repeats as well as TPR (tetratricopeptide) repeats, and together form an alpha helical 
domain that take on a “C” shape and wraps around the PI3K domain (Yang et al., 2013). The 
FAT domain contacts the PI3K domain with residues that are conserved within mTOR orthologs 
and these residues are important for mTOR function (Yang et al., 2013). The FRB (FKBP12 
Rapamycin Binding) domain is formed by four alpha helices and sits within the PI3K domain in 
mTOR (Yang et al., 2013) The FRB domain is a regulatory domain since it can inhibit 
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Figure 1. Schematic of the arrangement of the domains in wildtype Tra1.  A. The orientation 
of the domains within Tra1/TRRAP is outlined with the projected secondary structure 
underneath. B. The differences between the domain orientation of Tra1 and TRRAP are shown. 
Knutson and Hahn, (2011). 
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mTOR function when it is bound by rapamycin and FKBP12 (reviewed by Huang et al., 2003). 
The PI3K domain resembles the PI3K lipid kinases (Berndt et al., 2010; Lempiäinen and 
Halazonetis, 2009; Yang et al., 2013) and consists of two lobes, the N-terminal lobe and the C-
terminal lobe, with a cleft region between the two lobes where ATP can bind (Yang et al., 2013). 
Lastly, the FATC (FAT C-terminus) domain is a small 33-35 residue domain at the C-terminus 
of the PIKK proteins and consists of alpha helices (Dames et al., 2005; Yang et al., 2013). In 
mTOR, the FATC domain contains cysteine residues which were thought to form a loop between 
the helices (Dames et al., 2005). The formation of a loop within the FATC domain was not seen 
in the mTOR crystal structure by Yang et al., (2013). The role of the FATC domain is crucial for 
stability and kinase function of the PIKK proteins which contain kinase activity (Morita et al., 
2007; Jiang et al., 2006; Rivera-Calzada, 2005). Interestingly, the FATC domain is so highly 
conserved among some of the PIKKs that they are interchangeable (Sommer et al., 2013). For 
example, the FATC domain of Tel1/ATM can be replaced by the FATC of DNA-PKcs, 
Tra1/TRRAP, or Tor/mTOR (Jiang et al., 2006; Sommer et al., 2013). This does not hold true 
for all PIKKs since the FATC domain of Tel1/ATM cannot replace the FATC of Mec1/ATR or 
Tor/mTOR (Takahashi et al., 2000; Mordes et al., 2008). 
4. Transcriptional Regulators: Complexes associated with Tra1 
a. SAGA 
The SAGA (Spt-Ada-Gcn5 Acetyltransferase) complex was first identified in S. 
cerevisiae and is a large 1.8 MDa complex with 19 subunits (Figure 2). As stated in Rodríguez-
Navarro (2009), SAGA is modular with histone acetyltransferase (HAT), deubiquitylation, 
mRNA export, and promoter recruitment modules. The largest subunit within SAGA is Tra1. 
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Figure 2. Schematic of the SAGA (Spt-Ada-Gcn5 Acetyltransferase) complex. A. The 
structure of SAGA was determined using electron microscopy. Tra1 is positioned at the edge of 
the complex. Wu et al., (2004). B. A list of all the subunits in SAGA.  
  
A B 
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Within the SAGA complex, Tra1 is thought to play an integral role in transcriptional activation 
via interactions with gene specific activators (Fishburn et al., 2005).  
The Spt3 and Spt8 proteins within the SAGA complex aid in transcriptional regulation by 
recruiting TATA-binding proteins (Eisenmann et al., 1992; Eisenmann et al., 1994). Both have 
been shown to directly interact with TBP proteins (Dudley et al., 1999a; Bhaumik and Green, 
2002). Interestingly, Spt3 and Spt8 can also repress transcription (Belotserkovskaya et al., 2000). 
How these proteins distinguish between transcription activation and repression remains 
unknown. 
The structural integrity of the SAGA complex is achieved by a group of proteins called 
SPT (SuPressor of Ty) and TAF (TATA-binding protein-Associated Factor) proteins and Ada1 
(Sterner et al., 1999; Grant et al., 1998a). The structural module is composed of Spt7, and Spt20; 
while the TAF proteins include Taf5, 6, 9, 10, and 12 which also have a role in the general PolII 
transcription factor TFIID (Sterner et al., 1999; Grant et al., 1998a). An spt7 deletion strain 
showed a loss of SAGA complex integrity revealing the subunit’s importance for SAGA 
formation (Wu and Winston, 2002).  
The histone acetyltransferase (HAT) module in SAGA includes Ngg1, Ada2, Gcn5, and 
Sgf 29 (Horiuchi et al., 1995; Balasubramanian et al., 2002; Samara and Wolberger, 2011). In 
particular, this module of SAGA acetylates histone H3 at K9, K14, K18, and K23 as well as 
having some activity on histone H4 and histone H2B (Grant et al., 1999; Pray-Grant et al., 
2005). Gcn5 is the main catalytic subunit, Ngg1 is important for assessing lysine specificity and 
Ada2 aids with the complex’s catalytic activity (Balasubramanian et al., 2002). In addition to 
transcription activation, acetylation of the nucleosomes aids in transcription elongation. 
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Releasing DNA from the nucleosome helps to increase RNAPII processivity (Govind et al., 
2007). As stated by Budillon et al., (2007), acetylation is multifaceted and known to play several 
other roles in the cell aside from chromatin remodelling, such as the regulation of protein 
function (Budillon et al., 2007).  
The SAGA complex also modifies chromatin through deubiquitylation by Ubp8, Sgf11, 
Sus1, and Sgf73 (Koutou et al., 2010). Ubp8 is the catalytic protein of the module and Sgf73 
links the module to the rest of the SAGA complex (Henry et al., 2003; Khöler et al., 2008). 
SAGA deubiquitylation occurs on histone H2B in yeast (Daniel et al., 2004). When the 
deubiquitylation activity of the SAGA module is disrupted, the methylation of histone H3 is also 
affected (Henry et al., 2003). This highlights the complexity of the SAGA deubiquitylation 
function. Alone Ubp8 lacks deubiquitylation activity and requires the presence of the other 
module components which most likely causes a conformational change in the protein (Bonnet et 
al., 2008; Lee et al., 2005). Without Sgf73, the deubiquitylation complex is no longer bound to 
SAGA yet the deubiquitylation complex retains its activity (Khöler et al., 2006). This suggests a 
role for the deubiquitylation module outside of SAGA (Khöler et al., 2006). As well, Sus1 is 
involved with mRNA export and interacts with the TREX2 RNA export complex (Khöler et al., 
2008). While it is unclear whether Sus1 acts in the TREX2 complex with other SAGA 
constituents, the dual roles of Sus1 connect SAGA to mRNA transport (Khöler et al., 2008).  
There is an alternate form of SAGA in S. cerevisiae called SLIK (SAGA-Like) (Pray-
Grant et al., 2002). SAGA and SLIK share many of the same proteins including Tra1. 
Additionally, SLIK also contains acetylation and deubiquitylation activity which is catalyzed by 
Gcn5 and Ubp8, respectively (Pray-Grant et al., 2005). Notably, SLIK differs from SAGA in 
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that the Spt7 within SLIK contains a C-terminal truncation and Spt8 is not included in the 
complex (Belotserkovskaya et al., 2000; Pray-Grant et al., 2002).  
b. NuA4 
NuA4 (NUcleosome Acetyltransferase of histone H4), an essential 1.3MDa transcription 
regulatory complex in S. cerevisiae, also includes Tra1 (Allard, 1999). NuA4 contains 
acetyltransferase activity and is involved in transcription activation and the DNA repair pathway 
(reviewed in Doyon and Cote, 2004). The NuA4 complex contains approximately 13 proteins in 
S. cerevisiae and approximately 15 associated proteins in mammalian cells (Figure 3) (Doyon 
and Cote, 2004). Eaf1 acts as the NuA4 complex scaffold much like Spt7 in SAGA; in the 
absence of Eaf1, the structural integrity of NuA4 is lost (Auger et al., 2008; Chittuluru et al., 
2011). The catalytic component of NuA4 is the acetyltransferase Esa1, an essential protein in 
yeast (Tip60 in mammalian cells) (Allard, 1999). NuA4 specifically acetylates K5, K8, K12, and 
K16 on histone H4 and it also acetylates lysine residues on histone H2A in vivo (Allard, 1999). 
There are three other proteins, Epl1, Eaf6, and Yng2 (EPC1, mEAF6, and ING3, respectively, in 
mammalian cells), that work in subcomplex with Esa1 to allow for acetyltransferase activity 
(Doyon and Cote, 2004; Lu et al., 2009). Together with Esa1, this complex is named piccolo 
NuA4 (Boudreault et al., 2003). As a full complex, NuA4 only acetylates histones at specific 
genes; however, piccolo NuA4 has broader acetylation function (Boudreault et al., 2003). To 
access the DNA wrapped around histone H2A, NuA4 works in tandem with the Swr1 complex, 
which removes histone H2A and replaces it with the histone H2A variant Hzt1 (H2A.Z in 
mammalians) (Kobor et al., 2004). This is followed by NuA4 acetylation at the N-terminal tail of 
the histone (Keogh et al., 2006).  
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Figure 3. NuA4 schematic of the organization of the subunits and EM image of NuA4. A. A 
schematic image of the organization and orientation of the subunits of the NuA4 complex where 
Tra1 is bound to Eaf1 (From Chittuluru et al., 2011, based off of Doyon and Cote, 2004). F. 
Electron microscopy image of the NuA4 complex shown from each side. Chittuluru et al., 
(2011). 
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Much like its role in SAGA, Tra1 is involved with transcriptional regulation in NuA4 
(Brown et al., 2001). Tra1 recruits the NuA4 complex to gene-specific promoter regions (Brown 
et al., 2001). Once recruited to the promoter, NuA4 acetylates histones and transcription can be 
activated (Brown et al., 2001; Doyon and Cote, 2004).  
Arp4 and Esa1 are necessary for the recruitment of the NuA4 complex at sites of 
chromatin remodelling to signal DNA repair (Brown et al., 2001; Steinboeck et al., 2007). Esa1 
acetylation by NuA4 is required in the repair of double stranded breaks (Bird et al., 2002). Arp4, 
which typically binds histones, recognizes the phosphorylated histone H2A at the site of the 
break (Bird et al., 2002; Downs et al., 2004). Esa1 and Apr4 directly interact and together recruit 
NuA4 to the site of a double stranded break (Steinboeck et al., 2007). 
The presence of Tra1/TRRAP in multiple complexes, illustrates the versatility and 
importance of Tra1/TRRAP in the cell. 
c. ASTRA 
ASTRA (ASsembly of Tel, Rvb, and Atm-like kinase) is the name given a group of seven 
associated proteins, Rvb1, Rvb2, Asa1, Tel2, Tti1, Tti2, and Tra1/TRRAP, each of which is 
essential (Shevchenko et al., 2008). The ASTRA proteins were found to interact via a set of co-
immunoprecipitation experiments (Shevchenko et al., 2008; Stirling et al., 2011). The function 
of ASTRA within the cell is unclear but preliminary studies suggest that the components are 
required for chromosome integrity (Stirling et al., 2011). However, there are some questions that 
remain with regard to the function and even the existence of ASTRA, since the intact complex 
has not been isolated.  
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Rvb1 and Rvb2 are members of the AAA+ (ATPases Associated with diverse cellular 
Activities) protein family and partner with various chaperone and chromatin remodelling 
complexes (Shen et al., 2000; Kanemaki et al., 1999; Makino et al., 1998). These AAA+ 
proteins function in several cellular pathways including DNA repair and transcription (Shen et 
al., 2000). Tel2, Tti1, and Tti2 together form a complex called the TTT complex (Hurov et al., 
2010). Tti1 and Tti2 were both identified as proteins involved in the DNA damage response 
pathway (Hurov et al., 2010). In the absence of Tti1, cells cannot arrest in G2 phase or stop DNA 
replication in the response to irradiation (Hurov et al., 2010). Asa1 is a protein involved in 
telomere maintenance along with Tel2 and Tti1 (Stirling et al., 2011). In addition to its telomeric 
role, Asa1 is thought to aid the TTT complex with the biogenesis of various PIKKs (Stirling et 
al., 2011).  
The TTT complex interacts with PIKKs, particularly newly synthesized PIKKs (Takai et al., 
2010). This interaction is short lived and thought to be an important step in the formation of 
PIKKs (Takai et al, 2010). HSP90 (heat shock protein 90) also interacts with the TTT complex, 
supporting the hypothesis that the TTT complex is a chaperone (Takai et al., 2010). HSP90 and 
the TTT complex are both required for the proper maturation of the newly synthesized PIKKs 
(Takai et al., 2010). All three proteins, Tti1, Tti2, and Tel2, are required to form a stable 
complex (Hurov et al., 2010, Takai et al., 2010).  
5. Tra1/TRRAP  
Tra1 is a 433 kDa essential protein with roles in the SAGA complex, the NuA4 complex, and 
ASTRA as well as some independent functions (Saleh et al., 1998; Hoke et al., 2008; Helmlinger 
et al., 2011; Stirling et al., 2011). Its human homologue TRRAP (TRansformation/tRanscription 
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domain Associated Protein) is found in related complexes. A main characteristic of the PIKK 
family is that they contain a kinase domain; however, Tra1 does not have kinase activity (Saleh 
et al., 1998). While no enzymatic activity of Tra1/TRRAP has been determined, mutation studies 
show that the PI3K domain is important for Tra1 function. A mutation was created in the Tra1 
PI3K domain and converts a serine followed by two arginines to three alanines in Tra1 at 
positions 3413-3415 (tra1-SRR3413-3415AAA). tra1-SRR3413-3415AAA results in slow growth 
at 37°C, on 6% ethanol, and 5µg/mL of Calcofluor white plates grown at 30°C (Mutiu et al., 
2007). In addition to its slow growth defects, it was found that this mutation resulted in 
generation dependent telomere shortening (Mutiu et al., 2007). It is unknown whether this effect 
is direct or indirect (Mutiu et al., 2007).  
A modelled structure of the FATC domain from Tor1 depicted its C-terminus pointing in 
towards the active site of the protein (Lempiäinen and Halazonetis, 2009). The model shows the 
activation site residues from the PI3K domain forming a pocket. This pocket includes the FATC 
domain and the ATP binding site (Lempiäinen and Halazonetis, 2009). The structure of DNA-
PKcs was also modelled by Sibanda et al. (2010), and it showed a similar interaction between the 
FATC domain and the PI3K domain. It was not until recently that a crystal structure was solved 
for a portion of a PIKK protein, mTOR (Yang et al., 2013). This crystal structure presents the 
FATC domain of mTOR looping back to interact with the PI3K domain, similar to the modelled 
structures (Yang et al., 2013; Sibanda et al., 2010; Lempiäinen and Halazonetis, 2009). 
Analysing the crystal structure of mTOR shows the FATC domain surrounding the activation 
loop (Figure 4) (Yang et al., 2013).  
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Figure 4. Crystal Structure of mTOR in complex with Lst8. The crystal structure of the FAT, 
FBR, PI3K, and FATC domains of mTOR are shown. The FATC domain is dark purple, the 
ATP residue is orange and the C-terminal lobe of the PI3K kinase domain is light purple. The C-
terminal end of the FATC domain wraps around the C-terminal lobe of the PI3K domain. Yang 
et al., (2013). 
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To better understand the role of the Tra1 FATC domain, mutagenesis experiments were 
performed. Two mutations were created within the FATC domain of Tra1. A mutation from a 
leucine to an alanine at position 3733 in Tra1 was generated (tra1-L3733A) (Hoke et al., 2010). 
This mutation showed slow growth when grown under stress conditions such as on YPD (yeast 
peptone dextrose) plates grown at 37°C, on plates containing either 6% ethanol, 5µg/mL of 
Calcofluor white, or 1nM rapamycin (Figure 5) (Hoke et al., 2010). The C-terminal residue of 
Tra1 was mutated from a phenylalanine to an alanine (Tra1-F3744A) (Genereaux et al., 2012). 
The Tra1-F3744A mutation showed slow growth under the same conditions as Tra1-L3733A 
(Figure 5) (Hoke et al., 2010). This growth sensitivity demonstrates the importance of the C-
terminus of the FATC domain. Interestingly, the leucine at position 3733 is highly conserved 
among Tra1/TRRAP from various species and among differing PIKKs, and the terminal residue 
of the PIKKs is always large and hydrophobic but not always phenylalanine (Figure 6) (Hoke et 
al., 2010). A third mutation where a glycine residue was added to the C-terminus of Tra1 was 
created to determine its effect on Tra1 and cell viability (Hoke et al., 2010). The addition of the 
C-terminal glycine residue resulted in inviability (Hoke et al., 2010), further supporting the 
notion that the C-terminal residues of Tra1 are important for function. 
The C-terminal mutations of Tra1 can be suppressed by both intragenic and extragenic 
mutations. Tra1-N3677D and Tra1-T3716A, found in the PI3K domain and FATC domain, 
respectively, rescued the slow growth phenotype of Tra1-L3733A when cells were grown on 4% 
ethanol at 30°C (Hoke et al., 2010). Moreover, novel extragenic mutations were found to 
suppress both the phenotypes resulting from Tra1-L3733A and Tra1-F3744A (Genereaux et al., 
2012). Tti2-F328S and Tti2-I336F will suppress both of the Tra1 C-terminal mutations and based 
on the known chaperone functions of Tti2 are thought to function by stabilizing and assisting in  
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Figure 5. Phenotype of tra1-F3744A and tra1-L3733A under various stress conditions. A 
serial dilution of each haploid cell cultures of each genomically integrated mutation and wildtype 
allele were plated onto YPD grown at 30°C or 37°C, or YPD containing 5 µg/ml Calcofluor 
white (CW), 1 nM rapamycin, or 6% ethanol grown at 30°C. The tra1-F3744A and tra1-L3733A 
are boxed in red. Hoke et al., (2010). 
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Figure 6. FATC Sequence Alignment. Using the Clustal W program, a sequence alignment of 
the FATC domains across various species of Tra1 (top portion) and different PIKK proteins 
(bottom portion) were generated. The conserved leucine residue at position 3733 and the residues 
at position 3744 are denoted by a red arrow. Hoke et al., (2010). 
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the folding of Tra1/TRRAP thus implicating the FATC domain in these processes (Genereaux et 
al., 2012).  
Unlike Saccharomyces cerevisiae, Schizosaccharomyces pombe contains two copies of Tra1, 
Tra1 and Tra2. Tra1 is a component of SAGA and ASTRA and Tra2 a component of NuA4 
(Helmlinger et al., 2011). Interestingly, only Tra2 is required for cell viability (Helmlinger et al., 
2011). Since tra1Δ strains are viable, it allowed Helmlinger et al., (2011) the opportunity to 
explore the cellular function of Tra1. Tra1 was long thought to be a scaffold protein for the 
SAGA complex due to its large size (Knutson and Hahn, 2011). Rather, Tra1 deletion in S. 
pombe showed that Tra1 is not required for the assembly of the SAGA complex (Helmlinger et 
al., 2011). Secondly, it was noted that only specific genes were activated by SAGA and Tra1 
(Helmlinger et al., 2011). Based on genome-wide expression changes and chromatin 
immunoprecipitation assays, SAGA was found to have both Tra1 dependent and independent 
recruitment to promoters (Helmlinger et al., 2011). This datum suggests that Tra1 contains a 
specific regulatory role within SAGA. Originally, Tra1 was thought to have a global recruitment 
effect to promoters in the SAGA complex, but the ability for SAGA to be targeted to a promoter 
without Tra1 suggests that Tra1 is required for specific genes (Helmlinger et al., 2011). 
6. Tti2 
S. cerevisiae Tti2 (Tel two interacting protein 2) is a 421 amino acid residue protein found 
associated with Tel2 and Tti1 in the TTT complex (Hurov et al., 2010) and also the putative 
ASTRA complex. There is a TTT complex in S. pombe; however, it differs slightly from S. 
cerevisiae (reviewed by Kanoh and Yanagida, 2007). In S. pombe, Tel2 and Tti1 are strongly 
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associated with one another and these two proteins are similarly important for interaction with 
PIKKs (Kanoh and Yanagida, 2007); however, the interaction of Tel2 with Tti2 is not as strong.  
As previously stated, Genereaux et al., (2012) identified two tti2 mutations that rescue the 
slow growth phenotype caused by Tra1-F3744A and Tra1-L3733A. The two tti2 mutations that 
resulted in suppression are a phenylalanine to a serine at position 328 (Tti2-F328S) and an 
isoleucine to a phenylalanine at position 336 (Tti2-I336F) (Genereauxet al., 2012). Tti2-F328S 
demonstrated slightly better suppression than Tti2-I336F and was pursued with further 
experiments (Figure 7) (Genereaux et al., 2012). Tti2-F328S suppresses two different mutations 
in the FATC domain, but was unable to suppress mutations in the Tra1 PI3K domain, nor was it 
able to suppress the deletion of other components of SAGA, such as spt7and ada2 (Genereaux et 
al., 2012). This suggests that although Tti2-F328S does not directly interact with the terminal 
residue of the tra1-F3744A mutant allele, the suppression is allele specific to Tra1 (Genereaux et 
al., 2012). Tti2 suppression was found to be partially dominant and the mechanism of the 
suppression is thought to be through the stabilization and folding of Tra1 (Genereaux et al., 
2012). Western blots performed with Tra1-F3744A in the presence or absence of the tti2-F328S 
suppressor indicates that Tti2-F328S increases the level of Tra1-F3744A (Genereaux et al., 
2012). The tra1-F3744A allele also reduces the protein’s nuclear localization, particularly under 
conditions of stress (Genereaux et al., 2012). In the presence of the Tti2-F328S suppressor, this 
effect was partially reversed (Genereaux et al., 2012). These results suggest that Tti2 may aid in 
the proper folding and stability of Tra1.  
7. Mec1/ATR  
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Figure 7. Suppression of tra1-F3744A by Tti2-F328S (Sup3) and Tti2-I336F (SupB). 
Genomically integrated tra1-F3744A haploids containing either no suppressor, Tti2-F328S 
(SUP3), or Tti2-I336F (SUPB) were grown to stationary phase and spotted onto either YPD 
grown at 30°C or 37°C, or YPD containing 6% ethanol grown at 30°C. Genereaux et al., (2012). 
A wildtype Tra1 haploid (TRA1) was used as a positive control.  
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Mec1 and its human homolog ATR are also members of the PIKK family (reviewed in 
Abraham 2001). Mec1 is an essential protein with a mass of approximately 273 kDa (Cortez et 
al., 2001; Brown and Baltimore, 2003). The FATC domain of Mec1 is similar to Tra1 (Figure 8) 
though some differences are noted. For example, the last two residues of Mec1 are a 
phenylalanine followed by a tryptophan; this is reversed in Tra1.  
Unlike Tra1, Mec1 has kinase activity with substrates including Rad9 (in DNA damage), 
Cdc13 (in telomere recruitment), and Ies4 (in checkpoint response to DNA damage) (Emili, 
1998; Tseng et al., 2006; Morrison et al., 2007). Mec1 has several roles within the cell: 
maintaining the integrity of replication forks, and initiating cell cycle checkpoints and DNA 
repair pathways (Lopes et al., 2001). Given that Mec1 plays such a crucial role at the S-phase 
checkpoint in the cell cycle, it is highly regulated (Friedel et al., 2009). Mec1 is activated under 
stress conditions such as DNA damage during S-phase or stalling of the replication fork (Friedel 
et al., 2009). To activate Mec1, there are three proteins that come together and form a clamp 
called the 9-1-1 clamp which is loaded at the site of DNA damage (Burtelow et al., 2001; Majka 
et al., 2006). RPA (replication protein A) and its co-factor, Lcd1/Ddc2 (ATR-Interacting-Protein, 
or ATRIP in mammalians), recruit Mec1 to the site of DNA damage (Zou and Elledge, 2003; 
Dubrana et al., 2007). Both Lcd1/Ddc2 and the 9-1-1 clamp are required for activation of Mec1 
(Majka et al., 2006; Delacroix et al., 2007). Once activated, Mec1 phosphorylates components of 
the DNA repair cascade. In the case of Mec1 signalling during S-phase, Mec1 interacts with a 
different set of proteins. Firstly, Mec1 activates Chk1 and Rad53 (or CHK1 and CHK2 in 
mammals) via phosphorylation (Friedel et al., 2009). These two kinases then continue the 
activation cascade leading to various outcomes such as cell cycle arrest and replication fork 
stabilization (Hirao et al., 2000; Matsuoka et al., 2007). Recently, Rodríguez and Tsukiyama 
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 Figure 8. Sequence alignment of the FATC domains of S. cerevisiae Tra1 and Mec1 
proteins using the MUSCLE sequence alignment program. 
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 (2013) provided evidence that Mec1 may also stabilize replication forks under stress conditions 
by facilitating the accessibility of chromatin and increasing replication fork progression. The role 
of Mec1 in DNA damage response and replication fork stability makes it a possible drug target 
for DNA damage or cell cycle related diseases. 
Due to the sequence and likely structural similarities between Tra1 and Mec1, studies of 
Mec1, important in their own right, also increase our understanding of Tra1. In addition, the 
kinase activity of Mec1 provides another assay to validate function. 
Similar to Tra1-F3744A, mutations were introduced at the C-terminal end of Mec1. Mec1-
W2368A and Mec1-G2369 also share the slow growth phenotype and inviability seen by Tra1-
F3744A and Tra1-G3745, respectively (DaSilva et al., In press). Deletion mutations of Mec1 
were also created at the C-terminus. The Mec1 mutations where the last amino acid (mec1-Δ1), 
the last two amino acids (mec1-Δ2), or the last three amino acids (mec1-Δ3) of mec1 are deleted 
were found not to support viability (DaSilva et al., In press). Western blots were performed with 
all five of these mutations (DaSilva et al., In press). From these blots, Mec1-W2368A and Mec1-
G2369 were present at levels that are near wildtype, whereas the deletion mutations had lower 
expression with the lowest protein levels being found with the mec1-Δ3 mutation (DaSilva et al., 
In press). With the mec1-W2368A and mec1-G2369 mutations, both mirroring the results of the 
tra1-F3744A and tra1-G3745 mutations, it would be expected that the Tti2-F328S suppressor 
could rescue the Mec1-W2368A slow growth phenotype. However, the Tra1-F3744A 
suppressor, Tti2-F328S, does not rescue the Mec1-W2368A phenotype (Genereaux et al., 2012).  
Kinase assays and immunoprecipitation assays were performed to investigate the mechanism 
by which the mec1 mutations reduced function (DaSilva et al., In press). From 
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immunoprecipitation experiments, it was clear that the mutations were capable of interaction 
with Lcd1/Ddc2 and that this was not the source of reduced function. On the other hand, all of 
the Mec1 derivatives showed dramatically reduced kinase activity in vitro with only Mec1-
W2368A showing any activity above background. Together this datum clearly identifies a 
functional role for the C-terminal residue of Mec1. 
8. Concluding Remarks 
The results found from the tra1-F3744A experiments as well as the discovery of the Tti2-
F328S suppressor were the basis of my thesis. The goals of my thesis were to determine the 
sequence constraints of the C-terminal residues of Tra1, address using molecular tools whether 
the C-terminus may have a role outside of folding, and initiate the characterization of Tti2 at the 
molecular level. Specific objectives were to: (1) Characterize the role of the FATC domain 
of Tra1 using mutation and suppressor analysis of Tra1; (2) Determine which regions 
within Tti2 are required for viability, function, and interaction with the TTT complex 
components; (3) As a result of the parallels between Tra1 and Mec1, I also was involved in 
a project to identify suppressor mutations of Mec1-W2368A, to further characterize the 
role of the FATC domain in PIKK function. 
PIKKs have key roles in various cellular pathways, which include DNA repair, transcription 
activation, cell nutrient signalling and mRNA nonsense-mediated decay. In humans a defect in 
any one of these pathways can result in disease. A better understanding of PIKKs and their 
function will lead to avenues for therapies. The phenotypes of cells carrying mutations in the 
FATC domain demonstrate the importance of this domain for Tra1 function (Hoke et al., 2010). 
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Further exploration of this region is required to gain full comprehension of the function of the 
FATC domain in Tra1.  
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Chapter 2: Materials and Methods 
1. Yeast strains 
A list of the Saccharomyces cerevisiae strains used in this work can be found in Table S1 
under Supplemental Data. The FLAG-tagged tra1 C-terminal mutations were generated from 
strain CY4398, a diploid strain containing one of the tra1 alleles with a 5x-FLAG tag, by 
genomically integrating plasmids CB2485, CB2486, CB2487, CB2488, and CB2489 (Table S3), 
after digestion with SphI and SacI. His+ transformants were sequenced to confirm the integration 
of C-terminal tra1 mutations (see Section 4). The resulting heterozygous diploid yeast strains 
CY6497 (tra1-F3744S), CY6507 (tra1-WF-FW), CY6508 (tra1-Δ1), and CY6509 (tra1-Δ2) 
contained their respective FLAG-tagged tra1 C-terminal mutation. CY6514 (tra1-F3744R) was 
generated the same way but was integrated on the untagged allele. CY6499 (tra1-F3744S with 
tti2-F328S), CY503 (tra1-WF-FW) and CY6504 (tra1-WF-FW with tti2-F328S) were obtained 
by sporulating the diploid mutants (see Section 3). 
CY6145 (tti2-53-421 on a LEU2 centromeric plasmid) and CY6513 (TTI2 on a LEU2 
centromeric plasmid) were created by plasmid shuffling (Section 8). CB2494 and CB2327 
plasmids were transformed individually into CY6070 (tti2 deletion strain containing TTI2 on a 
URA3 plasmid). Plasmid shuffling was used to remove CB2319 (TTI2 with URA3 centromeric 
plasmid) while retaining the LEU2 centromeric plasmid containing either tti2-53-421 mutation or 
TTI2. These strains were then used for growth assay experiments.  
2. DNA constructs 
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A list of the DNA oligonucleotides and plasmids used can be found in Table S2 and 
Table S3, respectively. The tti2 truncation mutations were generated using two different 
approaches. The first approach was implemented to generate the N-terminal deletions (CB2491, 
CB2492, CB2493, and CB2494) and the internal segment (CB2595) of TTI2. Oligonucleotides 
6173-1, 6173-2, 6173-3, and 6223-1were created for the different N-terminal start sites and 
oligonucleotide 5693-2 or 6312-1 (for the internal segment) was used to amplify the C-terminal 
region of tti2. Once the region of interest was amplified using PCR, the PCR product was ligated 
into the pGEM T-Easy Vector® (Promega). Each pGEM plasmid was transformed into 
Escherichia coli and sequenced. From the pGEM plasmid, the tti2 truncation region was digested 
using NotI and SacI and ligated into CB2134 (9x myc tagged TTI2 on a LEU2 centromeric 
plasmid), replacing the same fragment from wildtype TTI2 gene. The newly ligated tti2 
truncation mutations were transformed into E. coli and confirmed by sequencing. The remaining 
tti2 variants were created by removing fragments of the tti2 gene from CB2134 using restriction 
enzymes NdeI, EcoRI, or BstBI. For CB2321 (tti2-1-238), NdeI was used to cut once at the site 
of base pair 716. The overhang ends were processed by Klenow (Fermentas) to produce blunt 
ends and then re-ligated. For CB2320 (tti2-1-165) EcoRI was used to cut at a site 495 in tti2 and 
at a site found in the polylinker of the vector. For CB2490 (tti2-Δ108-216), BstBI1 was used to 
cut at two sites within TTI2, at 312 and 648. The digested vector was gel purified then re-ligated. 
The ligated plasmids were transformed into E. coli and sequenced to ensure the tti2 truncations. 
Plasmid constructs CB2485 (tra1-F3744S), CB2486 (tra1-F3744R), and CB2488 (tra1-
Δ1) were generated in a similar manner using oligonucleotides 6238-1, 6238-2, and 6260-1, 
respectively, with primer 5747-1 to amplify the downstream region of the CB2147 vector from 
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the tra1 gene. These PCR products were ligated into CB2151 after digestion with NcoI and SacI 
and the constructs were sequenced.  
For CB2487 (tra1-WF-FW) and CB2489 (tra1-Δ2) oligonucleotides 6241-1 and 4249-3, 
and 6260-2 and 4249-3, respectively, were used to amplify the C-terminal region of tra1 using 
CB2147 as template. The PCR product was digested with BamHI and NcoI and used in a triple 
ligation with a vector obtained by digesting CB2151 with NcoI and SphI, and a second BamHI 
and SphI insert fragment from TRA1 from base pairs 1049 to 5794. The ligations were 
transformed into E. coli and the tra1 gene was sequenced to ensure the presence of the tra1 
mutation. 
3. Viability Assays using Sporulation 
For sporulation of diploid yeast strains, cells were first grown to stationary phase in one 
milliliter of YPD (2% peptone, 1% yeast extract, 2% dextrose). The yeast cells were washed 
twice with three milliliters of water before resuspending in three milliliters of 1% potassium 
acetate. The cells were grown for three to five days at 30°C. Tetrads were treated with 10 µL 
lyticase (5 µg/mL) to 30 µL of cells in 300 µL of sterile water and incubating for 12 minutes at 
25ºC. The haploid spores were then dissected and grown at 25°C for three days until spore 
colonies appeared. The spore colonies were genotyped by plating on synthetic complete (SC) 
media lacking leucine plates to check for the YHR100C/GEP4 plasmid (either CB1932 or 
CB2331), SC lacking uracil to check for the FLAG tag, and SC lacking histidine to check for the 
tra1 allele. Spores that grew on both the leucine-depleted and histidine-depleted plates were 
crossed with tester MAT a and MAT α haploid strains to ensure they were haploids. The genomic 
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DNA of true haploids was isolated and a PCR product of the tra1 C-terminus were sent for 
sequencing (see Section 4) to confirm the presence of the mutation.  
4. Preparation of Genomic DNA from Yeast for Sequencing 
To determine if the tra1 mutation was correctly integrated into the yeast genome, the 
genomic DNA was isolated and a PCR product of the tra1 C-terminus was sent for sequencing. 
Yeast cells were grown to stationary phase in five milliliters of YPD. The cells were harvested, 
washed once with water and resuspended in 200 µL of Hoffman Buffer (2% Triton X-100, 1% 
SDS, 100 mM NaCl, 10 mM Tris-Cl pH8, 1 mM EDTA), 200 µL of phenol, pH 8, and 0.3 g of 
acid washed 0.5 mm glass beads. The cells were vortexed for two to three minutes and then 
debris pellet by centrifugation at 10 000 x g for three minutes. The supernatant was collected and 
2.5 times the volume of 95% ethanol was added and the sample incubated at 25ºC for 30 
minutes. The samples were centrifuged again at 10 000 x g for three minutes to pellet the DNA. 
The RNA was removed from the genomic DNA by gel purification and extraction using phenol, 
pH 8.0, and chloroform isoamyl alcohol (24:1 – chloroform to isoamyl alcohol). The DNA pellet 
from the gel extraction was resuspended in 100 µL of water and one microliter was used for the 
template of the PCR to amplify the region of interest using primers 4225-7 and 4479-1 (see 
Section 5). The primers amplify the TRA1 gene from base pair 10950 to 11300, which includes 
65 bases downstream of the stop codon. After the region of interest is amplified, the DNA was 
again gel purified. DNA concentrations were determined based on the concentration of the DNA 
ladder and the DNA was resuspended to a concentration of 30-50ng/µL. One microliter was 
added into a 1:9 dilution with sterile water to send for sequencing. 
5. PCR  
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PCR reactions contained 1 µL of template DNA (1:500 dilution of mini prep plasmid 
stock), 1 µL of primers (final concentration of 1.25 pmol), and 10 µL of 2x PCR-EZ D-PCR 
Master Mix® (Bio Basic), were added to a final volume of 20 µL. The PCR reactions begin with 
an incubation at 94°C for five minutes to denature the DNA, followed by 25 or 30 (for genomic 
DNA) cycles with incubations at 94°C for 45 seconds, 45 seconds at 54°C to anneal the primers, 
and an extension of 1 minute for every 1000 bases of product at 72°C.  
6. Growth Assays 
One colony of haploid strains CY4353 (TRA1), CY6499 (tra1-F3744S with tti2-F328S), 
CY6503 (tra1-WF-FW), CY6504 (tra1-WF-FW with tti2-F328S), CY6513 (TTI2), or CY6145 
(tti2-53-421) was grown to stationary phase at 30ºC in one milliliter of YPD. The culture was 
first diluted 100-fold then serial dilutions of 10-fold each were made. Three microliters of each 
dilution were plated onto YPD or YPD containing either 6% ethanol, 0.2M hydroxyurea (HU), 
2nM rapamycin or 200µg/µL 6- azauracil (AU). Plates were grown at 30°C unless otherwise 
stated.  
7. Western Blot 
Ten milliliters cultures of yeast strain CY4118 (TAP-tagged TEL2 strain) containing 
plasmids CB2320, CB2321, CB2327, CB2490, CB2491, CB2492, CB2493, CB2494, or CB2495 
were grown in SC lacking leucine at 30°C to an OD600~2.0. Ten milliliters of diploid strains 
CY6497 (FLAG tagged tra1-F3744S), CY6507 (FLAG tagged tra1-WF-FW), CY6508 (FLAG 
tagged tra1-Δ1), CY6509 (FLAG tagged tra1-Δ2), CY4419 (FLAG tagged TRA1), CY4421 
(FLAG tagged tra1-F3744A), or BY4743 (untagged TRA1) containing plasmids CB1932 or 
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CB2331, were grown in YPD at either 30ºC or 37ºC until an OD600~2.0. Cells were lysed using 
the glass bead protocol described in Hoke et al. (2010). Protein concentration of the cell lysate 
was determined using the Bradford assay reagent (BioRad). Fifty micrograms of the tra1 
mutation protein extracts or 70 µg of the tti2mutation protein extracts was separated by SDS-
PAGE (SDS polyacrylamide gel electrophoresis) followed by transfer of the protein to a PVDF 
membrane and Western blotted following the protocol found in Mutiu et al. (2007). To probe 
with the anti-calmodulin binding protein (CBP) antibody, first the PVDF membrane was 
incubated in Casein blocking buffer (Sigma) overnight followed by a two hour incubation in 
anti-CBP antibody. Three four minute washes were performed using TBS (150mM NaCl and 
20mM Tris, pH 7.5) before incubating the membranes in Casein blocking buffer for another two 
hours. The membrane was incubated in anti-rabbit IgG HRP antibody for 45 minutes. Two four 
minute washes with TBS and one six minute wash with TBST (TBS with 0.5% Tween 20) were 
performed before visualising the protein signal. The following antibodies were used: anti-c-myc 
(Sigma, cat#M5546) primary antibody at 1:4000, anti-FLAG (Sigma, cat#F3165) primary 
antibody at 1:4000, anti-Calmodulin Binding Protein (Millipore, cat#07-482) primary antibody at 
1:1000, anti-mouse IgG HRP (Promega, cat#W4021) at 1:10000 , and anti-rabbit IgG HRP 
(Promega, cat#W4011) at 1:15000. The protein signal was visualised on film after detection with 
Supersignal West Pico Chemiluminescent Substrate (Thermo Scientific). The bottom half of the 
SDS PAGE gel was removed and stained overnight in Coomassie Brilliant Blue stain (45% 
methanol, 10% acetic acid, and 0.5 g/L R-250 C-Blue (BDH)) to determine the protein loading 
levels. The gel was destained overnight in 5% acetic acid and 40% methanol. Densitometry data 
was obtained using AlphaImager 3400 software (Alpha Innotech, San Leandro, CA).  
8. Plasmid Shuffling 
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Each of the tti2-containing plasmids, CB2320, CB2321, CB2327, CB2490, CB2491, 
CB2492, CB2493, CB2494, or CB2495 was transformed into yeast strain CY6070, individually, 
and grown in one milliliter of SC media lacking leucine at 30°C until stationary phase. One 
microliter of culture was transferred to one milliliter of YPD and grown to stationary phase at 
30°C to enable the loss of the TTI2-URA3 plasmid (CB2319). Serial dilutions of each culture 
were made and three microliters was spotted onto 5-fluoroorotic acid (5-FOA) plates and 
incubated at 30°C for two days. 
9. Co-immunoprecipitation experiments 
Five hundred milliliter cultures of either CY4118 (tel2-TAP tagged) or CY4119 (tti1-
TAP tagged) containing plasmids encoding wildtype or mutant tti2 (CB2320, CB2321, CB2327, 
CB2490, CB2491, CB2492, CB2493, CB2494, or CB2495) were grown at 30°C in YPD media 
to an OD600 ~2.0-3.0. The cells were lysed in liquid nitrogen as described in Saleh et al., (1997). 
The affinity purification (co-IP) assays were performed following the protocol from Rigaut et al., 
(1999). For each immunoprecipitation, 600 µL of rabbit IgG agarose beads (Sigma) was used. 
Forty milligrams of protein was applied to the column for the Tel2 co-IP while 30 mg of protein 
was applied to the columns for the Tti1 co-IP. The protein was eluted off the IgG agarose column 
using 3 µL of TEV enzyme (Invitrogen) to cleave the TAP tag. The calmodulin column binding 
and elution steps were omitted from the protocol. Prior to separating the eluted protein on a 
12.5% SDS polyacrylamide gel, the protein elution samples were precipitated using a 
trichloroacetic acid (TCA) (Ozols, 1990). Once the precipitated pellets were dry, 30 µL of 3x 
SDS loading buffer was added and the protein was separated by electrophoresis on a 12.5% 
SDS-PAGE gel, transferred to a PVDF membrane and immunoblotted for the proteins of 
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interest. Prior to blotting with anti-CBP, the protein was stripped using a stripping buffer 
containing 1% Tween 20 (Fisher Scientific), 15g/L glycine (Fisher Scientific), and 1g/L sodium 
dodecyl sulfate (SDS) (BDH). The PVDF membrane was incubated in 25mL of the stripping 
buffer for 10 min twice followed by two incubations in TBS (150mM NaCl and 20mM Tris, pH 
7.5) for 10 min each and two incubations in TBST (TBS with 0.5% Tween 20) for 5 min each.  
10. Bioinformatics analysis of mec1-W2368A suppressors 
Nine extragenic mec1-W2368A suppressors were discovered by Dr. Chris Brandl and sent 
to Biodiversity Research Centre (University of British Columbia, Vancouver, Canada) for paired 
end sequencing using the Illumina platform. All of the samples were sequenced in the same lane. 
Barcoding and library construction was performed at Biodiversity Research Centre. The map 
reads and quality files were assessed using the program Bowtie (Langmead et al., 2009). The 
reference Saccharomyces cerevisiae genome was downloaded from Saccharomyces Genome 
Database on March 24, 2011. The datum analysis was performed the same as described in 
Genereaux et al. (2012) with minor changes to the Perl and Shell scripts which were made to 
accommodate the script to the Illumina dataset (Supplemental Data, Figures S1-3). In addition to 
analysing the datum through the Bowtie program, one suppressor sample was also analysed 
using Novoalign (Hercus, 2013) to examine the sequence for any insertions or deletions. The 
Perl script for the Novoalign sequence analysis can be found in the Supplemental Data, Figure 
S4. A novoindex was created using the same S. cerevisiae reference genome. CY6267 (mec1-
W2368A suppressor strain) was mated with CY6076 (mec1-W2368A strain) to obtain spore 
colonies containing the suppressor mutation. These spore colonies had a portion of the Hkr1 
gene amplified using oligonucleotides 6529-1 and 6529-2 to identify the presence of the 
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suppressor. The method of preparing the genomic DNA for sequencing is the same as stated in 
Section 4. Spore colonies without the suppressor were also sequenced as a control. 
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Results 
Chapter 3: 
1. Rationale: 
Mutational analysis at the C-terminus of Tra1 was previously examined by changing the 
terminal phenylalanine of Tra1 to an alanine (tra1-F3744A) as well as adding a glycine to the C-
terminus (tra1-G3745) (Hoke et al., 2010). Both of these mutations demonstrated that the C-
terminus is important for the proper function of Tra1. The tra1-F3744A mutation resulted in 
yeast strains with slow growth at 37°C, in media containing 6% ethanol and calcofluor white, 
among other stresses (Hoke et al., 2010). The protein level of Tra1-F3744A was lower than that 
of wildtype and this level was recovered in the presence of the Tti2-F328S suppressor 
(Genereaux et al., 2012). This increase in protein expression led to the hypothesis that the C-
terminus of Tra1 is important for its folding and stability. This hypothesis is supported by the 
known interaction of PIKK proteins with the TTT complex (which contains Tti2) and heat shock 
proteins (Takai et al., 2010). However, when the tra1-G3745 mutation was analysed, the results 
suggested that the role of the C-terminus may be more complex (Hoke et al., 2010). First, the 
addition of a glycine residue (G3745) to the C-terminus renders the cell inviable. Second, the 
Tti2-F328S suppressor was not able to rescue the cells containing tra1-G3745. This was 
surprising since Tti2-F328S was able to suppress another FATC mutation, tra1-L3733A, thus 
indicating that the Tti2-F328S suppressor does not function specifically at the terminal residue. 
Together, this raises the possibility that the C-terminus of Tra1 has a role other than in proper 
folding. Yang et al. (2013) recently solved the crystal structure of mTOR from the FAT domain 
through to the C-terminus. This structure clearly shows that the FATC domain of mTOR 
interacts with its PI3K activation loop (Yang et al., 2013). Yang et al. (2013), propose that the 
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FATC domain aids in stabilizing the activation loop. If the C-terminus of Tra1 is similarly 
placed, it would be in a position where it may be a functional component of the protein.  
To begin to address this question, the sequence constraints at the C-terminus of Tra1 must 
be evaluated. To determine the sequence constraints, various mutations were constructed at the 
C-terminus of Tra1; these included altering the terminal phenylalanine to a serine (tra1-F3744S) 
or an arginine (tra1-F3744R), switching the terminal phenylalanine and the penultimate 
tryptophan (tra1-WF-FW), and deleting one or two residues at the C-terminus (tra1-Δ1and tra1-
Δ2) (Figure 9). A serine mutation was introduced at the C-terminus to test for the effect of a 
polar residue and be a direct comparison with the alanine mutation which results in a phenotype, 
likely due to improper folding. Another substitution mutation made at the C-terminus was 
changing the terminal phenylalanine to an arginine (tra1-F3744R), to determine the effect of a 
positively charged residue at the C-terminus of Tra1. The last substitution mutation made was a 
switch between the last two residues of Tra1 (tra1-WF-FW). For many PIKKs the last two 
residues are a phenylalanine followed by a tryptophan; however, in Tra1, these residues are 
reversed with a tryptophan followed by a phenylalanine. While Mec1 shares certain sequence 
similarity with Tra1, the Tti2-F328S suppressor is surprisingly unable to suppress the mec1-
W2368A phenotype. Mec1 also contains the phenylalanine followed by a tryptophan pattern at its 
C-terminus and may explain why the mec1-W2368A phenotype cannot be suppressed by Tti2-
F328S. Therefore the order of the last two residues of Tra1 may be a unique feature of Tra1. 
To further explore the role of the C-terminal carboxyl group of Tra1, two deletion 
mutations were made where the last residue or the last two residues were deleted. The choice to  
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RKVAQLGHLNSTPTVTTQFILDCIGSAVSPRNLARTDVNFMPWF 
RKVAQLGHLNSTPTVTTQFILDCIGSAVSPRNLARTDVNFMPWS 
RKVAQLGHLNSTPTVTTQFILDCIGSAVSPRNLARTDVNFMPWR 
RKVAQLGHLNSTPTVTTQFILDCIGSAVSPRNLARTDVNFMPFW 
RKVAQLGHLNSTPTVTTQFILDCIGSAVSPRNLARTDVNFMPW 
RKVAQLGHLNSTPTVTTQFILDCIGSAVSPRNLARTDVNFMP 
3744 3701 
Tra1 
Tra1-F3744S 
Tra1-F3744R 
Tra1-WF-FW 
Tra1-Δ1 
Tra1-Δ2 
Figure 9. Diagram of mutations created in Tra1. 
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remove two residues from the C-terminus of Tra1 was based on the structure which shows 
several helices located in this region. The helical structure of the C-terminal end of the protein 
would cause the carboxyl group to point out in different directions as the amino acids are being 
deleted. This change in direction of the carboxyl group could cause structural instability; 
therefore to ensure that any phenotype seen from these mutations is not due to the carboxyl 
group pointing in the wrong direction, two mutations were created.  
2. Results: 
The Tra1 substitution and deletion mutations were genomically integrated into a diploid 
TRA1 strain. The resulting yeast strain contains one wildtype allele and one mutated allele. To 
determine viability of the cells containing the tra1 mutation, the diploid cells were sporulated by 
subjecting the cells to a low nitrogen environment. This environment causes the diploid cell to 
sporulate into a tetrad of four haploid spores. These spores were dissected and plated on a YPD 
plate to grow at room temperature. Since each spore should have either a mutated or wildtype 
tra1 allele, viability can be assessed based on how many spore colonies grow. To determine if a 
spore colony contains a wildtype or mutated allele, genotyping was done with the viable spore 
colonies. However, when making the mutation to the TRA1 allele, a gene nearby called GEP4 
could be disrupted due to the mutagenesis process. To avoid misinterpreting inviability due to a 
change to the GEP4 allele, wildtype GEP4 was reintroduced into the cell on a plasmid. When the 
viable spores are genotyped for the mutation, they are also genotyped for the GEP4 plasmid 
which contains a LEU2 marker. Only those spore colonies containing the GEP4 plasmid were 
used for the viability assay results.  
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To determine if Tti2-F328S would suppress the lethality of the tra1-F3744S mutation, I 
sporulated the diploid cells and then checked for the presence of tra1-F3744S spore colonies. 
The tra1-F3744S mutation is linked to HIS3, and the GEP4 plasmid or GEP4 with tti2-F328S 
(GEP4/tti2-F328S) plasmid contains a LEU2 gene. For the tra1-F3744S mutation, none of the 
spore colonies with the serine mutation in the tra1 allele were viable (Table 1). To assess if the 
Tti2-F328S suppressor was able to rescue the tra1-F3744S mutation, tti2-F328S was introduced 
into the diploid strain prior to sporulation on a plasmid along with GEP4. When the Tti2-F328S 
suppressor was introduced into the strain, seven tra1-F3744S haploid cells were viable (Table 
2). To ensure that the spore colonies were haploid, they were mated with a tester alpha and A 
mating strain. If the spore cells only mate with one of the tester strains, then it is a true haploid 
cell. The tra1 allele of the haploid cells was subsequently sequenced after PCR from the genome 
to ensure the presence of the mutation. 
Growth of a haploid strain containing tra1-F3744S and the tti2-F328S suppressor was 
analyzed to see if the mutation results in a phenotype (Figure 10). The strain was grown to 
stationary phase in a one milliliter YPD culture. The culture was serially diluted in water, the 
first dilution being a 100 times dilution followed by three serial 10-fold dilutions. Three 
microliters of each dilution was spotted onto YPD plates grown at 30°C or 37°C, and onto a 
YPD plate containing 6% ethanol grown at 30°C. A wildtype haploid spore colony was grown 
and plated alongside the tra1-F3744S spore colony as a control. The tra1-F3744S strain grows 
slowly on 6% ethanol plates and on YPD plates at 37°C (Figure 10).  
A western blot was performed to determine if the level of Tra1-F3744S protein changes in 
the presence or absence of the Tti2-F328S suppressor. A diploid strain containing one wildtype 
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Table 1. Summary of sporulation results for tra1 mutations containing the GEP4 plasmid. 
Mutation Total Spores 
Spores Containing 
GEP4 plasmid 
Viable Spores 
Containing the 
Mutation 
tra1-F3744S 80 15 0 
tra1-F3744R 112 20 0 
tra1-WF-FW 80 34 2 
tra1-Δ1 101 27 0 
tra1-Δ2 96 12 0 
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Table 2. Summary of sporulation results for tra1 mutations containing the GEP4/tti2-F328S 
plasmid. 
Mutation Total Spores 
Spores Containing 
GEP4/tti2-F328S 
plasmid 
Viable Spores 
Containing the 
Mutation 
tra1-F3744S 32 9 7 
tra1-F3744R 28 5 0 
tra1-WF-FW 56 16 9 
tra1-Δ1 72 12 0 
tra1-Δ2 96 16 0 
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Figure 10. Growth of the tra1-F3744S cells with Tti2-F328S suppressor under stress 
conditions. A wildtype TRA1 strain (Wildtype) and the tra1-F3744S mutant strain containing the 
Tti2-F328S suppressor (tra1FS tti2SUP) were grown in 1mL of YPD media at 30°C until 
stationary phase. Both strains are found in a haploid background with only one copy of TRA1 
present. The cultures were grown to stationary phase before being diluted once 100-fold 
followed by three serial dilutions of 10-fold. Three microliters of each dilution was plated onto 
either a YPD plate grown at 30°C or 37°C, or a YPD plate containing 6% ethanol grown at 30°C.
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allele and one FLAG tagged tra1-F3744S allele was grown in the presence or absence of the tti2-
F328S suppressor. The cultures were grown for eight hours at 30°C or 37°C before lysing the 
cells using glass beads. Fifty micrograms of protein from the whole cell lysate was separated by 
electrophoresis on a 5% SDS polyacrylamide gel and transferred to a PVDF membrane. The 
membrane was blotted for using an anti-FLAG antibody. The protein was visualised by 
chemiluminesence. For a protein loading control, the bottom of the 5% SDS-PAGE gel was 
removed before the protein was transferred to the PVDF membrane and stained with Coomassie 
Brilliant Blue stain (Figure 11 B). The protein levels of Tra1-F3744S at 30°C do not change 
whether the cells are grown in the absence or presence of the Tti2-F328S suppressor (compare 
lanes 4 and 5) (Figure 11 A). Although the levels of the Tra1-F3744A mutant do not increase in 
the presence of the suppressor at 30°C, the degradation pattern disappears which equally shows 
an increase in Tra1-F3744A stability (Figure 11 A). This advocates for a greater loss of activity 
with Tra1-F3744S than for Tra1-F3744A. This hypothesis is additionally supported by the 
results seen at 37°C. The level of Tra1-F3744S alone is lower than that of wildtype (compare 
lane 4 to lane 3) (Figure 11 A). The Tti2-F328S suppressor increases the level of Tra1-F3744S 
(compare lane 4 to lane 5) (Figure 11 A). The increased levels of Tra1-F3744S in the presence 
of Tti2-F328S are near wildtype (compare lane 5 to lane 3) (Figure 11 A). However, this 
increase in protein is not sufficient to completely rescue the slow growth phenotype of Tra1-
F3744S at 37°C (Figure 10).  
The tra1-F3744R mutation was also assessed for viability. For tra1-F3744R, no viable spore 
colonies contained the arginine mutation (Table 1). The same result was seen for spores 
containing the Tti2-F328S suppressor (Table 2). This result suggests that the arginine mutation 
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Figure 11. Western blot of Tra1-F3744S mutant with and without Tti2-F328S suppressor. 
A. Diploid strains of the Tra1-F3744S (tra1FS) mutation, in which one allele contained wildtype 
TRA1 and the other allele contained the FLAG tagged tra1 mutation gene, were grown in 10 mL 
of YPD either at 30°C (left) or 37°C (right). Both a strain containing the GEP4/tti2-F328S 
suppressor (SUP) and a strain containing only GEP4 (No SUP) were grown. After 8 hours of 
growth, the cells were lysed using glass beads and 50 µg of protein from the crude extract was 
separated by electrophoresis on a 5% SDS polyacrylamide gel. The gel was then transferred to a 
PVDF membrane where the protein was immunoblotted for using a FLAG antibody. Tra1 was 
visualised on the PVDF membrane using chemiluminescence. A strain containing FLAG tagged 
wildtype TRA1 (wildtype) and a strain containing untagged TRA1 (negative control) were used as 
controls. The Tra1-F3744A mutant (tra1FA) was also separated alongside the Tra1-F3744S 
mutant (tra1FS) at 30°C to help illustrate a change in protein levels of the Tra1 (433 kDa) protein 
in the presence or the absence of the Tti2-F328S suppressor. The wildtype sample was serially 
diluted from 50µg (UnD) either 1:4 and 1:16 for the 30°C or 1:2 and 1:4 for the 37°C. The Tra1 
protein is indicated by the red arrow. B. The bottom of the SDS PAGE gels was cut from the gel 
prior to transferring the protein to the PVDF membrane. The bottom gel was stained with 
Coomassie Brilliant Blue stain as a protein loading control. The gel corresponds to the 30ºC 
samples.
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interrupts the C-terminus of Tra1 to an extent greater than the other substitution alleles or affects 
a function not suppressible by Tti2-F328S. The positively charged side chain of the arginine 
amino acid may prevent the C-terminal tail from orienting into the proper conformation for 
stability and/or may disrupt a crucial interaction. If the terminal residue interacts with the 
activation loop of the PI3K domain, as shown in the mTOR structure, then the positive side chain 
may prevent the C-terminus from interacting with the PI3K domain (Yang et al., 2013).  
The next step for Tra1-F3744R would be to check for protein expression levels. 
Unfortunately, I was unable to obtain a diploid strain where the tra1-F3744R gene was FLAG 
tagged. I did transform tra1-F3744R into a diploid strain where both TRA1 alleles are FLAG 
tagged; however, the background signal from the remaining TRA1 FLAG tagged allele makes the 
results difficult to interpret.  
The same viability assay was also used to determine the viability of the tra1-WF-FW 
cells. Two tra1-WF-FW spore colonies could be identified with the tra1-WF-FW mutation 
(Table 1). In the presence of the Tti2-F328S suppressor, nine tra1-WF-FW spore colonies were 
viable and genotyped as true haploids containing the tra1-WF-FW gene by mating each spore 
colony with tester A and alpha strain (Table 2). The tra1 allele from the tra1-WF-FW spore 
colonies was sequenced to verify the presence of the mutation.  
The growth assay for the tra1-WF-FW mutation was performed similarly to those done 
for tra1-F3744S. A culture of the tra1-WF-FW haploid strain containing either the GEP4 
plasmid or the GEP4/tti2-F328S plasmid were grown and serially diluted. The dilutions were 
spotted onto a YPD plate grown at 30°C or 37°C (Figure 12). From these growth assays, the 
tra1-WF-FW strain without the suppressor grows slowly on YPD at 37ºC (Figure 12). This slow 
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Figure 12. Growth of the tra1-WF-FW mutation cells in the presence or absence of the Tti2-
F328S suppressor under stress conditions. A wildtype TRA1 strain (Wildtype) and the tra1-
WF-FW mutation strain were grown in 1 mL of YPD media at 30°C until stationary phase in the 
absence (tra1WF-FW tti2WT) or presence (tra1WF-FW tti2SUP) of Tti2-F328S suppressor. Both strains 
are found in a haploid background with only one copy of tra1 present. The saturated cultures 
were then diluted once 100-fold followed by three serial dilutions of 10-fold. Three microliters 
of each dilution was plated onto YPD plates and grown at 30°C or 37°C. 
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growth is suppressed by tti2-F328S (Figure 12).  
To see if there is any effect on protein stability of Tra1-WF-FW a western blot was 
performed. Figure 13 A shows the protein levels of Tra1-WF-FW with and without the Tti2-
F328S suppressor, grown at 30°C or 37°C. Figure 13 B shows the loading controls. The protein 
levels for Tra1-WF-FW are higher in cells containing the Tti2-F328S (compare lane 4 to lane 5) 
(Figure 13 A). The change in protein levels between the two Tra1-WF-FW samples resembles 
the change seen by the Tra1-F3744A mutation at 37°C (compare lanes 4 and 5 to lanes 6 and 7) 
(Figure 13 A). Although the suppressor increases the protein levels of Tra1-WF-FW, these 
levels are still lower than wildtype (compare lane 5 to lane 3) (Figure 13 A).This result would 
suggest that the suppressor aids in the stability and expression of the protein, similar to the tra1-
F3744A mutation.  
To understand the effect of the carboxyl group of Tra1, two deletion mutations were 
made: tra1-Δ1and tra1-Δ2. These mutations were created similarly to the substitution mutations 
and were integrated into the yeast genome. Likewise, viability assays were performed by 
sporulating the diploid cells containing the mutation. Neither of the two deletion mutations, tra1-
Δ1 nor tra1-Δ2, were viable in the absence or presence of Tti2-F328S (Tables 1 and 2). 
The Tra1-Δ1 and Tra1-Δ2 protein expression levels were analysed using western blots in 
a diploid background. The strains were grown both at 30°C or 37°C (Figure 14 A and Figure 15 
A). Figures 14 B and 15 B show the loading controls for Tra1-Δ1 and Tra1-Δ2, respectively. 
The presence of Tti2-F328S did not increase the expression levels seen for Tra1-Δ1 nor Tra1-Δ2 
(compare lane 4 to lane 5) (Figure 14 A and Figure 15 A). However, tra1-Δ1and tra1-Δ2 strains  
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Figure 13. Western blot of the Tra1-WF-FW mutation in the absence or presence of the 
Tti2-F328S suppressor. A. Diploid strains of the Tra1-WF-FW (tra1WF-FW) mutation, in which 
one allele contained wildtype TRA1 and the other allele contained the FLAG tagged tra1 
mutation gene, were grown in 10 mL of YPD either at 30°C (left) or 37°C (right). A strain 
containing the GEP4/tti2-F328S suppressor (SUP) and a strain containing only GEP4 (No SUP) 
were grown. After 8 hours of growth, the cells were lysed using glass beads and 50 µg of protein 
from the crude extract was separated by electrophoresis on a 5% SDS polyacrylamide gel. The 
gel was then transferred to a PVDF membrane where the protein was immunoblotted for using a 
FLAG antibody. Tra1 (433 kDa) was visualised on the PVDF membrane using 
chemiluminescence. A strain containing FLAG tagged wildtype TRA1 (wildtype) and a strain 
containing untagged TRA1 (negative control) were used as controls. The Tra1-F3744A mutation 
(tra1FA) was also separated alongside the Tra1-WF-FW mutations to help illustrate a change in 
protein levels of the Tra1 protein in the presence or absence of the Tti2-F328S suppressor. The 
wildtype sample was serially diluted from 50µg (UnD) to 1:16 and 1:4 at 30°C or 1:2 and 1:4 at 
37°C. The Tra1 protein is indicated by the red arrow. B. The bottom of the SDS PAGE gels was 
cut from the gel prior to transferring the protein to the PVDF membrane. The bottom gel was 
stained with Coomassie Brilliant Blue stain as a protein loading control. The left gel corresponds 
to the 30ºC samples and the right gel is the 37ºC samples. 
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Figure 14. Western blot of the Tra1-Δ1 deletion mutation in the absence or presence of the 
Tti2-F328S suppressor. A. Diploid strains of the Tra1-Δ1 mutation (tra1Δ1), in which one allele 
were grown in 10 mL of YPD either at 30°C (left) or 37°C (right). A strain containing the 
GEP4/tti2-F328S suppressor (SUP) and a strain containing only GEP4 (No SUP) were grown. 
After 8 hours of growth, the cells were lysed using glass beads and 50 µg of protein from the 
crude extract was separated by electrophoresis on a 5% SDS polyacrylamide gel. The gel was 
then transferred to a PVDF membrane where the protein was immunoblotted for using a FLAG 
antibody. Tra1 (433 kDa) was visualised on the PVDF membrane using chemiluminescence. A 
strain containing FLAG tagged wildtype TRA1 (wildtype) and a strain containing untagged TRA1 
(negative control) were used as controls. The wildtype sample was serially diluted from 50µg 
(UnD) to 1:2 and 1:4. The Tra1 protein is indicated by the red arrow. B. The bottom of the SDS 
PAGE gels was cut from the gel prior to transferring the protein to the PVDF membrane. The 
bottom gel was stained with Coomassie Brilliant Blue stain as a protein loading control. The left 
gel corresponds to the 30ºC samples and the right gel is the 37ºC samples. 
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Figure 15. Western blot of the Tra1-Δ2 deletion mutation in the absence or presence of 
Tti2-F328S suppressor. A. Diploid strains of the Tra1-Δ2 mutation (tra1Δ2), in which one allele 
contained wildtype TRA1 and the other allele contained the FLAG tagged tra1 mutation gene, 
were grown in 10 mL of YPD either at 30°C (left) or 37°C (right). A strain containing the 
GEP4/tti2-F328S suppressor (SUP) and a strain containing only GEP4 (No SUP) were grown. 
After 8 hours of growth, the cells were lysed using glass beads and 50 µg of protein from the 
crude extract was separated by electrophoresis on a 5% SDS polyacrylamide gel. The gel was 
then transferred to a PVDF membrane where the protein was immunoblotted for using a FLAG 
antibody. Tra1 (433 kDa) was visualised on the PVDF membrane using chemiluminescence. A 
strain containing FLAG tagged wildtype TRA1 (wildtype) and a strain containing untagged TRA1 
(negative control) were used as controls. The wildtype sample was serially diluted from 50µg 
(UnD) to 1:16 and 1:4 at 30°C or 1:2 and 1:4 at 37°C. The Tra1 protein is indicated by the red 
arrow. B. The bottom of the SDS PAGE gels was cut from the gel prior to transferring the 
protein to the PVDF membrane. The bottom gel was stained with Coomassie Brilliant Blue stain 
as a protein loading control. The left gel corresponds to the 30ºC samples and the right gel is the 
37ºC samples. 
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both showed a decrease in protein expression compared to wildtype, particularly at 37°C 
(compare lane 4 and 5 to lane 3) (Figure 14 A and Figure 15 A). 
Chapter 4: 
1. Rationale: 
Tti2 is part of the TTT complex which also includes Tti1 and Tel2. The exact function of this 
complex is unknown but it interacts with Hsp90, as well as members of the PIKK family, 
including Tra1 (Takai et al., 2010). Furthermore, Takai et al., (2010) have shown that the 
interaction of the TTT complex with PIKK proteins is short lived and occurs shortly after the 
PIKK protein is synthesized. This datum would suggest a role of the TTT complex in the folding 
of PIKK proteins. However, how the TTT complex helps with protein folding and the role of 
each individual protein in the complex remains unknown. As previously stated, Tti2-F328S 
suppresses two mutations within the Tra1 FATC domain, and, at least for tra1-F3744A, increases 
the protein levels thus reinforcing the hypothesis that the tti2-F328S suppressor has a role in 
protein folding.  
A comprehensive characterization of the Tti2 protein would provide a better understanding of 
the relationship between the tti2-F328S suppressor and the stabilization of Tra1-F3744A. Very 
little is currently known about Tti2. No structure or domain analysis has been revealed and no 
functional analysis has been undertaken. Therefore a tti2 truncation mutation analysis was 
performed to elucidate its domain features. Plasmid shuffling assays were done with the tti2 
truncation mutations to establish what regions are required for viability followed by co-
immunoprecipitation experiments to resolve which of these regions retain the ability to interact 
with the TTT complex binding partners.  
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With a better understanding of the functions of Tti2, we can start to piece together how Tti2-
F328S suppresses the tra1-F3744A mutation as well as gather evidence with regards to the 
overall function of wildtype Tti2 and its effects on wildtype Tra1.  
2. Results: 
To begin the analysis of wildtype Tti2, a set of tti2 gene truncation mutations were made in 
order to determine the regions necessary for viability. Figure 16 illustrates the regions that were 
deleted from Tti2. The N-terminal deletions, as well as, the internal Tti2 piece were generated 
using PCR with primers flanking the regions of interest. The PCR products were then ligated into 
a LEU2-containing centromeric plasmid. For the internal deletion (using BstBI) and the 1-165 
mutation (using EcoRI), the enzymes cut at two sites and the gene was ligated back together after 
the removal of the middle or end region. For the 1-238 fragment, the gene was digested with 
NdeI then the overhanging ends blunted before ligation, therefore causing a frame shift to the 
gene after base pair 716 (residue 238). For Tti2-1-238, the frame shift added an additional 15 
amino acids to the sequence while Tti2-1-165 contains an additional 27 amino acids. Much like 
the other deletions, the C-terminal deletions and the internal deletion were ligated into a LEU2-
containing centromeric plasmid. 
To check for viability of the tti2 truncation mutations, plasmid shuffling was used. The 
plasmids harbouring the tti2 mutations were individually transformed into a S. cerevisiae strain 
where tti2 is deleted from its genome and instead contains wildtype TTI2 on a plasmid with a 
URA3 marker. These transformed cells containing both plasmids were grown to stationary phase  
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Figure 16. Map of Tti2 truncation mutations. The thick black line encompasses the expressed 
region of the Tti2 protein. The residue numbers of Tti2 are indicated above the bars. 
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in selective media to retain the tti2 mutation plasmid. The cells from the selective media cultures 
were grown in YPD media to enable the loss of the wildtype TTI2 plasmid. These cultures were 
again grown to stationary phase and then plated on a 5-fluoroorotic acid (5-FOA) plate. If the 
cells lose the wildtype TTI2 plasmid and the tti2 truncation mutation can support viability, then 
the cells will grow on the 5-FOA plate. The wildtype TTI2 on a LEU2 centromeric plasmid was 
transformed into the same yeast tti2 deletion strain as a positive control. Of the deletion alleles 
only the tti2-53-421 supported viability (Figure 17). This demonstrates that the very N-terminus 
of the protein is not necessary for function. Since the tti2-1-238 mutation is not viable, this 
suggests that the Tti2-F328S suppressor mutation falls in a region required for function.  
Protein expression levels were examined for the tti2 truncation mutations by western 
blotting. The myc-tagged- tti2 plasmids were transformed into a yeast strain containing a 
genomic copy of wildtype TTI2 within its genome. This allows for all of the truncation mutations 
to be assessed for protein expression, even those mutations that are not viable. The transformed 
cells were grown in YPD media and then lysed using glass beads in the presence of protease 
inhibitors. Seventy micrograms of protein from the crude lysate was separated by electrophoresis 
on a 12.5% SDS polyacrylamide gels and transferred to a PVDF membrane. The protein was 
immunoblotted for using an anti-myc antibody and Tti2 was detected by chemiluminesence. A 
negative control strain lacking tagged Tti2 and a positive control containing myc tagged wildtype 
Tti2 were included. Figure 18 shows that six of the tti2 truncation mutations are expressed: Tti2-
53-421 (lane 3), Tti2-116-421 (lane 4), Tti2-53-238 (lane 7), Tti2-1-165 (lane 8), Tti2-1-238 
(lane 9), and Tti2-Δ108-216 (lane 10). For Tti2-116-421, Tti2-53-238, and Tti2-Δ108-216, the 
protein levels are lower than wildtype levels which suggests that the reason for inviability may  
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Figure 17. Viability assay of tti2 truncation mutations grown on 5-FOA after plasmid 
shuffling.  Each tti2 truncation mutation on a LEU2-containing centromeric plasmid (tti2-290-
421, tti2-206-421, tti2-116-421, tti2-Δ108-216, tti2-1-165, tti2-1-238, tti2-53-421, tti2-53-238) 
was transformed into a tti2 deletion strain where the wildtype TTI2 is found on a URA3 plasmid. 
After growing the strains with the tti2 truncation plasmids in selective media, the cells were 
transferred to YPD media and grown to stationary phase at 30°C. The cultures were diluted once 
100 fold then subsequently serially diluted 3 times at 10 fold (left to right). Each dilution was 
plated on a 5-FOA plate to check for viability. A control wildtype TTI2 on a LEU2-containing 
centromeric plasmid (TTI2) was also transformed into the Tti2 deletion strain, grown, and plated 
similarly to the mutations. 
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Figure 18. Western blot of Tti2 truncation mutations. The tti2 truncation plasmids and a 
wildtype TTI2 control plasmid were transformed into a wildtype background yeast strain. The 
strains were grown for 8 hours in 10 mL of YPD at 30°C. The cells were isolated and lysed using 
glass beads. Seventy micrograms of protein from the crude extracts were separated by 
electrophoresis on 12.5% SDS-polyacrylamide gels. The gels were then transferred to a PVDF 
membrane and the Tti2 protein was immunoblotted using the anti-myc antibody. 
Chemiluminescence was used to visualise the protein. As a control, a yeast strain was 
transformed with a plasmid lacking myc tagged TTI2 (Negative Control), as well as, a plasmid 
harbouring myc tagged wildtype TTI2 (Wildtype Tti2). The expressed Tti2 truncation mutations 
are highlighted by a red box (WT Tti2 – 60 kDa). 
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be due to protein instability (compare lanes 4, 7, and 10 with lane 2) (Figure 18). Tti2-53-421 
(lane 3), Tti2-1-238 (lane 9) and Tti2-1-165 (lane 8) all expressed near wildtype levels (lane 2). 
For the Tti2-1-165 mutation, the protein migrated with lower mobility on the gel than expected 
(lane 8). The tti2-1-165 gene was sequenced and shown to be correct.  
To determine if the tti2-53-421containing strain shows any phenotype under stress 
conditions, it was grown at 30°C on YPD plates containing either 6% ethanol, 0.2M hydroxyurea 
(interferes with the DNA replication pathway), 200µg/µL of 6-azauracil (interferes with 
transcription elongation), or 2nM rapamycin (interferes with signal transduction and amino acid 
utilization) and on a YPD plate at 30°C or 37°C (Hampsey, 1997). tti2-53-421 results in a slight 
slow growth phenotype at 37°C but not in any of the other stress conditions (Figure 19). These 
results indicate that the first 52 amino acids from the N-terminus of Tti2 can be deleted with only 
a minor temperature sensitivity phenotype. This is consistent with the N-terminal region of the 
protein being less highly conserved in the fungal species as shown in the sequence alignment of 
Figure 20. The highest degree of conservation can be found within the central region of the 
protein. 
Co-immunoprecipitation experiments were performed to determine if any of the truncation 
mutations retained the ability to interact with other members of the TTT complex. All of the 
expressed alleles of Tti2 were examined with the exception of tti2-Δ108-216 in the Tel2 co-IP 
and tti2-53-238 in the Tti1 co-IP. The tti2 truncations were expressed in a strain containing 
wildtype TTI2 and genomically encoded TAP tagged TTI1. These transformed strains were 
grown in 500 mL YPD cultures and lysed by grinding in liquid nitrogen. The crude cell extracts  
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Figure 19. Growth of assay of tti2-53-421 truncation mutation strain under stress 
conditions. The tti2 deletion strain containing either the wildtype TTI2 plasmid or the tti2-53-
421 plasmid were grown in 1 mL of YPD media at 30°C until stationary phase. The cultures 
were then diluted once 100-fold followed by 3 serial dilutions of 10-fold (from left to right). 
Three microliters of each dilution was plated onto either a YPD plate grown at 30°C or 37°C, 
and a YPD plate containing either 6% ethanol, 0.2M hydroxyurea, 200µg/µL of 6-azauracil, or 
2nM rapamycin. Each plate was grown at 30°C unless otherwise stated. mec2-1 is a control 
strain used to validate the hydroxyurea plates, Weinert et al., (1994). 
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were chromatographed over an IgG column which binds to the TAP tag. Three washes were 
performed before eluting Tti1 off the column using the Tobacco Etch Virus protease (TEV). The 
eluted protein was precipitated using trichloroacetic acid (TCA) and 2% sodium deoxycholate 
(DOC). All of the precipitated protein was separated by electrophoresis on a 12.5% SDS 
polyacrylamide gel along with 70 µg of protein from the crude lysate (Figure 21). An anti-myc 
antibody was used to detect Tti2. The input levels of the crude cell extracts indicate that each of 
the proteins is present (lanes 4 to 8) (Figure 21 A, C). For Tti2-53-421, the ratio of input to 
protein bound to Tti1 was similar to wildtype Tti2 (Figure 21 A and B). Densitometry indicated 
that the ratio was 0.4 to 0.5 fold increase in the inputs (Figure 22, 30 second exposure). For the 
other mutations, the amount bound to Tti1 is lower than the amount in the inputs (lane 5 to 8) 
(Figure 21 C and D). The protein band intensities for Tti2-1-238 and Tti2-1-165 dropped below 
the background intensity signal (Figure 22, 5 minute exposure). The fold change of Tti2-116-
421 and Tti2-Δ108-216 were 35.7 and 39.4, respectively, and the background fold change (-TAP 
control) was 15.7 (Figure 22, 5 minute exposure). Therefore, I conclude that only Tti2-53-421 
is able to interact with Tti1.  
To ensure that the Tti1 TAP tagged molecule was present within all the transformed cells 
used for the co-immunoprecipitation experiments, the same co-immunoprecipitation membranes 
were blotted with an anti-calmodulin binding protein (CBP) antibody (Figure 23). Within the 
TAP molecule bound to Tti1 is a calmodulin binding peptide which can be detected using this 
antibody. Tti1 was present in each of the samples used for the co-immunoprecipitation 
experiment with the exception of the untagged Tti1 control. 
The interaction datum with Tel2 is shown in the form of a histogram indicating the ratio of 
input versus co-immunoprecipitated (Figure 24). The interaction datum with Tel2 is shown in
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Figure 21. Co-immunoprecipitation assay of myc9-tagged tti2 truncation mutations with 
TAP-tagged Tti1 protein to check for interaction. The plasmids containing the tti2 truncations 
were transformed into a TAP-tagged Tti1 S. cerevisiae strain. The strains were grown in YPD 
media until stationary phase. The yeast cells were lysed and 30 mg of the protein extract was 
chromatographed on 600 µL of IgG agarose resin. TEV enzyme was used to cleave Tti1 from the 
TAP tag which allows Tti1 to elute off the column. The protein within the elution sample was 
precipitated using TCA and DOC. All of the precipitated protein (B, D) and 50µg of the protein 
lysate (A, C) was separated by electrophoresis on a 12.5% polyacrylamide gel. The protein on 
the gel was then transferred to a PVDF membrane. Tti2 was probed via an anti-myc antibody and 
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chemiluminescence was used to visualize the protein (A and B- 30 second exposure; C and D – 
5 minute exposure). The wildtype control is a plasmid containing the wildtype TTI2 with a myc 
tag and TAP-tagged TTI1. The negative controls are a wildtype strain with no myc tagged TTI2 
but retains the TAP tagged TTI1 (control –myc) and a wildtype strain with myc tagged TTI2 but 
no TAP tagged TTI1 (control –TAP). The bands enclosed in the red boxes are Tti2 (WT Tti2 – 
60 kDa). 
64 
 
 
Figure 22. Histograms of the Tti1 co-immunoprecipitation densitometry datum. A. The densitometry datum of the input and 
elution samples after exposing the film for 30 seconds. B. The densitometry datum of the input and elution samples after exposing the 
film for 5 minutes. IDV is equal to the sum of the pixel value of each band minus the background. The tables list the fold change from 
the elution samples to the input samples. Samples with negative values were not calculated. 
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Figure 23. Re-probe of TAP tagged Tti1 and myc9 tagged Tti2 co-immunoprecipitation 
experiment using CBP antibody. The input membrane used in the IP experiment was stripped 
of the myc antibody before re-blotting using an anti-CBP primary antibody. Chemiluminescence 
was used to visualize the protein (5 second exposure). The bands enclosed in the red boxes are 
Tti1 (119 kDa). Negative controls are a wildtype strain with no myc tagged TTI2 but retains the 
TAP tagged TTI1 (control –myc) and a wildtype strain with myc tagged TTI2 but no TAP tagged 
TTI1 (control –TAP). Wildtype is a plasmid containing the wildtype TTI2 with a myc tag and 
TAP-tagged TTI1.
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Figure 24. Histograms of the Tel2 co-immunoprecipitation densitometry datum. The densitometry datum of the input and elution 
samples after exposing the film for 5 minutes. IDV is equal to the sum of the pixel value of each band minus the background. The 
table lists the fold change from the elution samples to the input samples.
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the form of a histogram indicating the ratio of input versus co-immunoprecipitated (Figure 24). 
The ratios of input to elution of Tti2-53-421 is approximately 1.0 fold difference in the input 
than elution samples while the ratio for wildtype Tti2 is approximately 1.7 fold more in the input 
than elution samples (Figure 24). This indicates that Tti2-53-421 interacts with Tel2 at least as 
efficiently as the wildtype Tti2. Tti2-53-238 and Tti2-1-238 show a ratio of 4.8 and 3.2 fold 
more input than elution protein, respectively (Figure 24). This suggests that Tti2-53-238 and 
Tti2-1-238 interact with Tel2 but with low affinity (Figure 24). Tti2-1-165 and Tti2-116-421 did 
not appear to interact with Tel2. The densitometry intensity signal of Tti2-1-165 and Tti2-116-
421 were 14.4 and 7.3, respectively, and the background fold change (-TAP control) was 6.8 
(Figure 24). This datum suggests that the 53-238 region of Tti2 is required for interaction with 
Tel2. A portion of this region is missing from both Tti2-1-165 and Tti2-116-421. The tti2-116-
421 mutation suggests that the region of Tti2 between amino acids 53 to 116 is equally crucial 
for Tel2 binding (Figure 25). An anti-CBP western blot was performed to determine the level of 
Tel2 TAP tagged protein present in the samples (Figure 26). All of the samples, with the 
exception of the untagged Tel2 control, showed the presence of the Tel2 protein. 
The results from the experiments performed with the tti2 truncation mutations are 
summarized in Table 3. 
Chapter 5: 
1. Rationale 
Mec1 is an integral component of the DNA repair pathway, as well as, crucial for DNA 
replication fork stability (Lopes et al., 2001). This protein is a member of the PIKK family and is 
an active kinase with many phosphorylation targets (Emili 1998; Tseng et al., 2006; Morrison et  
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Figure 25. Schematic depicting the region of Tti2 required for interaction with Tel2 and 
Tti1. Schematic of the Tti2 protein sequences used in the co-immunoprecipitation experiments. 
The protein sequences boxed in blue are those that interact with both Tel2 and Tti1. The protein 
sequences boxed in orange are those that only interact with Tel2. 
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Figure 26. Re-probe for TAP tagged Tel2 in the myc9 tagged Tti2 co-immunoprecipitation 
experiment. The input membrane used in the IP experiment was stripped of the myc antibody 
before re-blotting using an anti-CBP primary antibody. Chemiluminescence was used to 
visualize the protein (30 second exposure). The bands enclosed in the red boxes are Tel2 (79 
kDa). Negative controls are a wildtype strain with no myc tagged TTI2 but retains the TAP 
tagged TEL2 (control –myc) and a wildtype strain with myc tagged TTI2 but no TAP tagged 
TEL2 (control –TAP). Wildtype is a plasmid containing the wildtype TTI2 with a myc tag and 
TAP-tagged TEL2. 
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Table 3. Summary of tti2 truncation mutations and their viability, expression, and 
interaction status. 
Mutation Viable  Expressed Interacts with Tel2 Interacts with Tti1 
tti2-53-421 Yes Yes Yes Yes 
tti2-116-421 No Yes No No 
tti2-206-421 No No - - 
tti2-290-421 No No - - 
tti2-1-165 No Yes No No 
tti2-1-238 No Yes Yes No 
tti2-Δ108-216 No Yes - No 
tti2-53-238 No Yes Yes - 
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al., 2007). Although its function is known and the pathways in which Mec1 is involved have 
been identified, the molecular mechanism for Mec1-dependent protein phosphorylation is poorly 
understood. It is hypothesised that the Mec1 protein phosphorylation activity relies on its C-
terminus (Nakada et al., 2005). Similar to Tra1, a series of Mec1 mutations have been generated 
including a substitution at the C-terminal residue of Mec1, mec1-W2368A. This mec1-W2368A 
mutation, like tra1-F3744A, is viable yet grows slowly under stress conditions (Dasilva et al., In 
press). The expression of this mutation is less than the wildtype suggesting that the phenotype is 
due to problems with mec1-W2368A folding and stability (DaSilva et al., In press). These results 
suggest that the C-terminus of Mec1, much like the C-terminus of Tra1, is important for cell 
viability and protein expression. We pursued further analysis of the Mec1 mutation because 
unlike Tra1, Mec1 has kinase activity that can be measured.  
Interestingly, Tti2-F328S, a suppressor of Tra1-F3744A, does not suppress the mec1-
W2368A phenotype (Genereaux et al., 2012). This is not believed to be the result of a specific 
interaction between Tti2-F328S and Tra1-F3744A since this suppressor can also suppress tra1-
L3733A. As we expected the mec1 mutations to fold incorrectly, we screened for suppressors of 
the slow growth properties caused by Mec1-W2368A. Additionally, finding a suppressor of 
Mec1-W2368A would increase our understanding of the proteins and pathways involved with 
regulation of Mec1. 
2. Results 
Extragenic suppressors that would allow growth of a strain containing mec1-W2368A at 37°C 
were selected after mutagenizing cells with a short exposure to ultraviolet light (DaSilva et al., In 
Press). Those cell colonies that showed faster growth at 37°C were isolated and backcrossed ten 
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times with the parent mec1-W2368A yeast strain. Backcrossing was performed to remove 
additional mutations from the suppressor genomes. After the backcrossing suppressor strains 
were sent for whole genome sequencing using Illumina sequencing technology. The suppressor 
discovery and backcrossing was performed by Julie Genereaux and Dr. Chris Brandl.  
The Bowtie software was used to map the suppressor Illumina sequencing datum to a 
reference genome acquired from Saccharomyces Genome Database (SGD; 
http://www.yeastgenome.org) (Langmead et al.,2009). The sequence variants in the reads 
compared to the reference were identified and organized into a table using SAMtools (Li et al., 
2009). The quality of the DNA sequence reads were assessed using the Phred score. Any variant 
within this table that did not meet a Phred quality score of 20 was eliminated from further 
analysis. A Phred score of 20 is equivalent to the presence of a single-nucleotide polymorphism 
(SNP) in 99% of the reads (Ewing et al., 1998). High quality variants detected in the wildtype 
control were subtracted from the variants detected in the suppressor set to enrich for variants 
resulting in suppression. These remaining variants were examined to determine if they were 
intragenic or extragenic. Only those intragenic variants were analysed to determine if the base 
change resulted in an amino acid change. Those variants that predicted an amino acid change 
within a gene were considered potential suppressors. 
From the nine samples sent for sequencing, three of these samples had a variant within a 
gene that was known to suppress a Mec1 mutation and were not analysed further. These three 
mutations are sml1-L62ochre (TAA), rfx1-S213N, and rfx1-S462L (Zhao et al., 1998; Huang et 
al., 1998). The discovery of these known suppressor genes added confidence to the method used 
for the suppressor variants screening.  
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Of the remaining six samples, one sample had a potential novel suppressor, a mutation in the 
rpn3 gene causing a leucine to proline change at residue 140 (Rpn3-L140P). To validate this 
mutation as the suppressor, the rpn3 gene was amplified and sequenced from the suppressor 
strain, in addition to creating the Rpn3-L140P mutation anew in the Mec1-W2368A background 
strain. Both were consistent with Rpn3-L140P being responsible for the suppression (DaSilva et 
al, In Press). Rpn3 is a component of the 19S regulatory cap of the 26S proteasome (Finley et al., 
1998). The specific role of Rpn3 is unclear but the cap is thought to be important in the 
recruitment of proteins to the proteasome for degradation (Finley et al., 1998). As reviewed in 
Hoyt and Coffino, (2004) and Sorokin et al., (2009), the proteasome can degrade both 
ubiquitinated (ubiquitin-dependent pathway) and non-ubiquitinated (ubiquitin-independent 
pathway) protein.  
To further ensure that Rpn3-L140P was the suppressor mutation, sequence coverage of the 
suppressor sample was analysed using the IGV (Integrative Genomics Viewer) program 
(Robinson et al., 2011). IGV is a program which visually displays mapped reads along the 
reference sequence to demonstrate coverage - the number of reads aligning to a base in the 
reference sequence. This allows for areas of low coverage to be easily seen. IGV also displays 
any base substitutions that may be present within the suppressor sample compared to the 
reference genome. From the linkage analysis it was clear that the suppressor, if not Rpn3-L140P, 
was closely linked to this mutation (DaSilva et al, In Press). Therefore, I focussed on analysing 
the coverage, 40,000 bases downstream and upstream of rpn3. Within the 80,000 base pair 
region, there were no regions of significant low coverage and there was only one base 
substitution found which causes a silent mutation within the zrg8 gene (Figure 27). This  
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Figure 27. Mapped reads to the region 40 kb downstream and upstream of the rpn3-L140P 
mutation using IGV. The blue arrow indicates the location of the rpn3-L140P mutation and the 
red box encloses the mapped reads
increased the confidence that Rpn3-L140P is the suppressor of Mec1-W2368A within this 
sample. 
The suppressor sequencing reads from the Rpn3-L140P sample were also analysed using 
Novoalign to ensure that there were no insertion or deletion (indel) mutations that could be 
responsible for the suppression (Hercus, 2013). From the Novoalign datum, there appears to be 
no indels within 50,000 base pairs upstream and 50,000 base pairs downstream. There was only 
one indel detected on chromosome V located approximately 75,000 bases upstream of the rpn3 
gene predicting a thymine insertion within a string of poly Ts. The evidence for this thymine 
insertion is of very low quality and occurs in only one read of all five reads that map to this 
region. Thus, there are no significant indels occurring within chromosome V and this supports 
Rpn3-L140P as the suppressor of the Mec1-W2368A mutation. 
From another suppressor sample, it appeared that Hkr1-V594A was a candidate for a 
potential suppressor. Hkr1 is a mucin gene involved in osmolarity regulation within the cell 
(Tatebayashi et al., 2007). However, upon amplification and sequencing of the gene from four 
different haploid colonies, two which demonstrate slow growth at 37°C and two which grow 
similarly to the wildtype control, all four HKR1 genes contained the Hkr1-V594A mutation. 
Therefore, hkr1 is not the suppressor gene for that sample. 
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Chapter 6: Discussion 
1. Prelude 
I will first discuss the effect that the C-terminal tra1 mutations have on Tra1 activity and 
what this reveals about the function of the FATC domain. The Tti2 truncations will likewise be 
discussed with a focus on their impact on Tti2 function, the TTT complex, and cell viability. 
Lastly, two potential hypotheses for the mechanism of the Rpn3-L140P suppressor of Mec1-
W2368A will be evaluated. Throughout, I will consider future work that could be undertaken. 
2. Differences in cell viability and protein expression for the tra1 C-terminal 
mutations 
Three substitution mutations (tra1-F3744S, tra1-F3744R, and tra1-WF-FW) and two 
deletion mutations (tra1-Δ1 and tra1-Δ2) were created at the C-terminus of tra1. Each mutation 
was assessed for cell viability and protein expression both in the presence or absence of the Tti2-
F328S suppressor. Only tra1-WF-FW was able to support viability without the suppressor, while 
tra1-F3744S and tra1-WF-FW allowed for cell viability in the presence of Tti2-F328S.  
The effect of Tra1-F3744S differed from the alanine mutation (tra1-F3744A) previously 
examined by Hoke et al., (2010). The tra1-F3744A mutation resulted in a phenotype when cells 
were grown under stress conditions. These phenotypes could be rescued in the presence of the 
Tti2-F328S (Hoke et al., 2010; Genereaux et al., 2012). Interestingly, Tra1-F3744S resulted in 
inviability in the absence of the suppressor and showed a phenotype when grown under stress 
conditions in the presence of the Tti2-F328S suppressor. Potential causes for these differences 
were further examined by comparing the protein levels of Tra1-F3744S. The level of Tra1-
F3744S increased in the presence of tti2-F238S when cells were grown at 37°C. This suggests a 
role for Tti2-F328S in Tra1-F3744S protein folding and/or stabilization. Tra1-F3744S levels in 
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the presence of the suppressor were comparable to wildtype, yet the F3744S mutation resulted in 
stress related growth defects. This may result from the tra1-F3744S mutation affecting the 
activity of Tra1 in addition to its folding. Tti2-F328S may aid with the folding of Tra1-F3744S 
but might not fix the interactions lost or compromised due to the polar group of the serine 
residue. To help support this possibility it would be valuable to examine the localization of Tra1-
F3744S, as perhaps the deficiency results from an inability to transport the protein into the 
nucleus. 
The tra1-F3744R mutation resulted in inviability in the presence or absence of the 
suppressor. The inability of the suppressor to assist Tra1-F3744R again would be consistent with 
the C-terminus of Tra1 playing a role beyond folding. The levels of Tra1-F3744R were not 
determined due to the inability to obtain tra1-F3744R on the FLAG tagged allele in a diploid 
strain. These protein levels should be examined in the future to determine if cell inviability is due 
to protein instability and what influence the suppressor has on Tra1-F3744R protein levels.  
The tra1-WF-FW containing cells were viable in the presence or absence of the suppressor. 
In isolation Tra1-WF-FW resulted in slow growth at 37°C; this phenotype was suppressed by 
Tti2-F328S. As well, Tra1-WF-FW levels increased in the presence of the suppressor at 37°C, 
similar to Tra1-F3744A. Suppression of tra1-WF-FW by the Tti2-F328S would suggest that the 
mutation primarily affects folding. The subtleties of the role of the C-terminal residues are 
clearly revealed by this mutation as it represents the switching of what are commonly thought of 
as functionally similar residues. And similar to the tra1-F3744A mutation, the result with this 
allele suggests that once the suppressor is able to adjust the residues into a functional and stable 
orientation, the protein is able to function correctly. These experiments further illustrate the 
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specificity and importance of the FATC domain of Tra1. This specificity could be the result of 
the terminal residue making important interactions with the PI3K domain that are necessary for 
folding. A detailed structure of the Tra1 FAT-PI3K-FATC regions would be invaluable in further 
evaluating the function of the C-terminal residue. 
It was seen from the crystal structure produced by Yang et al., (2013) that the C-terminus of 
mTOR interacts with the PI3K domain. This and our mutational analyses imply that the terminal 
amino acid is important for PI3K function. Alternatively, it may be the carboxyl group that is 
required for function. The tra1 deletion mutations were designed to test the role of the carboxyl 
group. Neither tra1-Δ1 nor tra1-Δ2 was viable in the presence or absence of the suppressor 
suggesting these deletions disrupt Tra1 activity or result in a folding defect that cannot be 
repaired by Tti2-F328S. The protein levels for each of the deletion mutations were below those 
levels seen for wildtype in the presence or absence of the Tti2 F328S suppressor. The deletion 
mutations show the importance of the interactions occurring at the C-terminus. Since there is no 
new amino acid being introduced into the sequence, it is unlikely that these mutations are 
sterically inhibited in their folding; however the terminal residue may still be involved in making 
key contacts for folding. Alternatively the result with the deletion derivatives may support a 
specific function for the C-terminal carboxyl. This lack of interaction may cause a loss of activity 
or it may prevent Tra1-Δ1 and Tra1-Δ2 from localizing to the nucleus. Kinase activity assays of 
Mec1-Δ1, Mec1-Δ2, and Mec1-Δ3 showed reduced activity compared to wildtype (DaSilva, et 
al., In press). Paralleling this datum with the tra1deletion mutations would also suggest that 
Tra1-Δ1 and Tra1-Δ2 influence protein activity.  
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Like Tra1, the mec1 deletion mutations similarly showed a reduction in protein levels 
(DaSilva et al., In press). In addition, the nuclear localization of Mec1-Δ1, Mec1-Δ2, and Mec1-
Δ3 was reduced (DaSilva et al., In press). This experiment should be repeated with the tra1 
deletion mutations. Additional mutations may help evaluate the role of the C-terminal carboxyl 
group. One potential mutation would be to remove the terminal phenylalanine and replace the 
penultimate tryptophan with a glutamic acid residue (Tra1-W3743E). If it is the carboxyl group 
that supports function for Tra1, then the glutamic acid side chain carboxyl may restore function 
to Tra1. It may be valuable to also perform this experiment with Mec1 protein as well where 
kinase assays could be analyzed. 
The reduction in protein levels was equally seen with Mec1-W2368A suggesting that the C-
terminus is not only important for Tra1 but for all PIKKs. The C-terminus of the FATC domain, 
however, is not present in PI3Ks (Yang et al., 2013). This indicates that the specificity and 
function of the terminal residue is unique to PIKKs and may be an important feature that 
differentiates the PIKKs from the PI3Ks. 
3. Regions of Tti2 required for viability correlate with interaction to the TTT 
complex component Tti1 
Very little is known about the structure and function of Tti2. The suppression of Tra1-
F3744A by Tti2-F328S (Genereaux et al. 2012), helped elucidate some of the molecular 
properties of Tra1. To better understand the relationship between Tra1 and Tti2, details of Tti2 
structure/function are required. From the viability assays and analysis of the protein levels, I 
demonstrated that the N-terminus of Tti2 (first 52 amino acids) can be deleted without any effect 
on protein level or cell viability. The tti2-53-421 mutation only demonstrated a slight 
temperature sensitivity, which suggests that this region does not provide any essential function 
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for Tti2. None of the other mutations, encompassing deletions of the middle regions or C-
terminal sequences supported viability and Tti2-206-421 and Tti2-290-421 were not expressed 
suggesting that there is a region between residues 116 and 206 that is required for protein 
stability. The expression of the tti2 truncation mutations was lower than wildtype with the 
exception of Tti2-53-421. The lower Tti2 expression levels could contribute to cell inviability for 
these mutations. Tti2, Tel2, and Tti1 are part of the TTT chaperone complex (Hurov et al., 2010; 
Takai et al., 2010). Particularly, the TTT complex is thought to assist with the folding of PIKKs, 
among which Tra1 and Mec1 are essential proteins in yeast (Takai et al., 2010). Insufficient TTT 
complex in the cell may deplete the PIKKs leading to growth defects or potentially cell death.  
Tti2-1-165 migrated more slowly than expected on SDS-PAGE. The reason for this is 
unclear. When the plasmid was generated and the internal piece of TTI2 was removed, it resulted 
in the protein shifting out of frame after residue 165. The frame shift caused an added 81 base 
pairs to be added to the 3’ end of tti2-1-165. The extra 27 amino acids would add approximately 
3.2 kDa to the molecular weight of Tti2-1-165. Similarly, Tti2-1-238 contained an extra 15 
residues at its C-terminus contributing to an increase of approximately 1.7 kDa.  
The ability of the Tti2 truncations to interact with the components of the TTT complex was 
determined using co-immunoprecipitation (co-IP) assays with TAP-tagged proteins. Co-IPs were 
performed with both Tel2 and Tti1. Tti2-53-421, Tti2-1-238, and Tti2-53-238 all co-
immunoprecipitated with Tel2; although Tti2-1-238 and Tti2-53-238 bound less efficiently. Tti2-
1-165 and Tti2-116-421 did not bind to Tel2. These results position the Tel2 interaction region 
between residues 53 and 238 of Tti2. The Tti1 co-IP demonstrated that Tti2-53-421 has a 
significantly greater ability to bind Tti1 than any of the other Tti2 truncations. This would 
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suggest interaction with Tti1 is an essential feature of Tti2 function. It is difficult to establish 
which region is required for binding to Tti1 since most of the truncation proteins did not bind. 
The lack of binding from the inviable tti2 truncation mutations may be an added affect with the 
lowered protein expression. It may be these two facets working together that prevent the TTT 
complex from forming which then results in cell inviability.  
To further explore the regions required for viability and TTT complex formation, more 
truncation mutations should be generated. The truncation mutations previously generated 
focussed more on narrowing the regions of viability at the N-terminus. tti2-1-238 was initially 
thought to be viable, so additional truncations were not made at the C-terminus. They are now 
being made to refine the C-terminal mapping. Tti2-53-238 and Tti2-Δ108-216 should be co-IPed 
with Tti1 and Tel2, respectively, to gain a better understanding of these truncation mutations. 
Other co-immunoprecipitation assays can be performed with the other interacting proteins of the 
putative ASTRA complex. By identifying the regions that are required for viability and those 
which are required for an interaction with a binding partner, essential interactions can be 
determined.  
4. Suppressor Identification Approach and Potential Mechanisms for Rpn3-
L140P Suppression of Mec1-W2368A  
a. Rpn3-L140P may disrupt the 26S proteasome and prevents Mec1-W2368A 
degradation 
Rpn3 is a constituent of the 26S proteasome. Its function within the proteasome is unclear but 
it is a member of the 19S regulatory particle, which is thought to aid in recruiting proteins to the 
proteasome for degradation (Finley, 1998). There are two hypotheses as to how Rpn3-L140P 
could function to help stabilize Mec1-W2368A. The first is that the mutation in rpn3 renders the 
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protein non-functional. If the 19S regulatory particle is no longer able to recruit proteins due to 
the loss of function of Rpn3-L140P, Mec1-W2368A may avoid degradation. If Mec1-W2368A is 
not readily degraded, this will give Mec1-W2368A more time to fold and it may give rise to a 
sufficient amount of functional protein. Experiments performed in the lab are consistent with 
Mec1 not being ubiquitinated suggesting that Mec1 is degraded by the ubiquitin-independent 
degradation pathway of the 26S proteasome or that Mec1 associates with another protein that is 
ubiquitinated and is carried to the proteasome via this secondary protein. In either case, the C-
terminus of Mec1 is unchanged due to ubiquitination leaving the possibility that if the 26S 
proteasome malfunctions (due to the rpn3-L140P mutation), Mec1-W2368A could fold into the 
correct confirmation to support cell viability.  
b. Rpn3 may act as a chaperone  
The second hypothesis is that the rpn3-L140P mutation helps Mec1-W2368A fold through 
chaperone activity. It has been described in the literature that certain components of the 19S 
regulatory particle may function to unfold proteins which enables them to enter the proteasome 
for degradation (reviewed in Elsasser and Finley, 2005). These components include Rpt1-6, 
which contains functional similarity to ATPase ring complexes which are known to aid in 
folding (reviewed in Elsasser and Finley, 2005). It may be that, along with the Rpt1-6 subunits, 
Rpn3 works as a chaperone and possesses the ability to assist with proper protein folding of 
select proteins. Mec1 may be one of these proteins and the mutation in rpn3-L140P may work 
directly or through other mechanisms to assist with folding of the Mec1-W2368A protein. 
Work performed by DaSilva et al., (In press), favour the first model where Rpn3-L140P 
allows more time for Mec1-W2368A to fold. An experiment where the proteasome was inhibited 
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by MG-132 also resulted in an increase in Mec1-W2368A protein levels, similar to the increase 
seen with Rpn3-L140P. Further experiments will need to be undertaken to clarify which of these 
two hypotheses is correct. These experiments could include making mutations in other 
proteasomal components and assessing their effect on Mec1-W2368A expression levels. 
Alternatively, the components of the 19S proteasomal cap have shown function in transcription 
as well, suggesting another possible pathway for suppression to occur (Ferdous et al. 2001; 
Gonzalez et al. 2002).  
C. Suppressor Identification Approach 
The approach taken to analyse the suppressors was to align the Illumina whole genome 
sample datum to a reference S. cerevisiae genome. This sequence alignment was done with a 
program called Bowtie (Langmead et al., 2009). Bowtie compares the sample datum to the 
reference genome and lists any position in the genome where a SNP (single-nucleotide 
polymorphism) occurs (Langmead et al., 2009). This variants list was then formatted into a table 
using SAMtools (Li et al., 2009). The table lists the nucleotide present in the genome, the SNP, 
and a quality or Phred score (Ewing et al., 1998). The Phred score is used to further narrow the 
search for the suppressor mutation by discarding any SNP which shows a Phred score of less 
than 20. A Phred score of 20 or higher means that the SNP is present ≥99% of the time (Ewing et 
al., 1998). After filtering the datum based on their Phred scores, the control sample was 
compared individually to each of the suppressor samples. Any SNP found in the suppressor 
sample that was also in the control sample was discarded. SNPs that fell in a non-coding region 
were equally discarded. The remaining SNPs were analyzed manually to determine the gene 
where the SNP occurs and if the nucleotide mutation results in an amino acid change.  
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Although this suppressor analysis approach has identified the novel Rpn3-L140P suppressor 
and three other known suppressors, there are certain limitations to the analysis which may have 
prevented the identification of the suppressor in the other samples. First, the Bowtie software 
used to identify the SNPs can only identify missense mutations, not insertions or deletions 
(indels). Other programs exist to examine sequencing data for indels. Novoalign is one such 
program and it was used to ensure the Rpn3-L140P suppressor dataset did not have any indels 
linked to rpn3 (Hercus, 2013). This program can also be used to examine the other datasets in a 
similar manner. Second, the Phred score may have been too stringent for the potential suppressor 
variants. The suppressor sample datum should be re-examined with a lower Phred score to see 
what new variants arise. Third, only coding regions of the genome were analysed. The potential 
suppressor may lie within non-coding regulatory regions. The method of suppression may be a 
change in the expression level of a certain protein and not a direct mutation within the gene. 
Non-coding regions should be investigated for any potential variants that lie within a regulatory 
region of a gene. Gene expression analysis programs can also be used to determine if a certain 
gene is under or over expressed in the suppressor background compared to the control.  
Overall, whole genome sequencing combined with bioinformatics is a powerful technique to 
identify suppressors within a genome. As the sequencing techniques and sequence analysis 
software improve, the possibility to identify suppressors also grows.  
5. Conclusions 
The experiments performed on the tra1-F3744S, tra1-F3744R, tra1-WF-FW, tra1-Δ1, and 
tra1-Δ2 mutations indicate that the C-terminus of Tra1 possesses a sequence specificity that is 
important for proper protein function and for folding. The effect these mutations have on the cell 
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show the importance of the C-terminus of Tra1 while the inability of the suppressor to rescue 
some of these mutations is indicative of a role for the C-terminal residue beyond folding. The 
role of the carboxyl group in Tra1 appears to be important for function and should be further 
explored. 
The truncation mutations of tti2 show that the N-terminus of Tti2 is not required for cell 
viability and that the tti2-F328S suppressor mutation lies in a region that is crucial for function. 
The inviable truncation mutations had lower expression and their ability to bind Tti1 was 
drastically decreased. Tti2-53-238 and Tti2-1-238 retained their interaction with Tel2, which 
suggests the region for binding Tel2 is between residues 53-238. These results are consistent 
with the formation of the TTT complex being necessary for viability. More mutations must be 
analyzed to gain a better understanding of the domain boundaries of Tti2. 
Rpn3-L140P was identified as a suppressor of the mec1-W2368A mutation using whole 
genome sequencing and bioinformatics. The mechanism by which the Rpn3-L140P suppressor 
functions to suppress the Mec1-W2368A phenotype is unclear. It may work to disrupt the 26S 
proteasome and therefore prevent Mec1-W2368A degradation or it may function as a chaperone 
and assist with Mec1-W2368A folding.  
 
 
  
86 
 
References 
Abraham R.T. (2001). Cell Cycle Checkpoint Signaling through the ATM and ATR Kinases. Genes Dev. (15): 
2177-2196. 
Adam M., Robert F., Larochelle M., and Gaudreau L. (2001) H2A.Z is Required for Global Chromatin Integrity and 
for Recruitment of RNA Polymerase II under Specific Conditions. Mol Cell Biol. (21): 6270-6279. 
Allard S., Utley R.T., Savard J., Clarke A., Grant P., Brandl C.J., Pillus L., Workman J.L., and CôtéJ. (1999) NuA4, 
an Essential Transcription Adaptor/Histone H4 Acetyltransferase Complex Containing Esa1p and the ATM-Related 
Cofactor Tra1p. EMBO J. (18): 5108-5119. 
Auger A., Galarneau L., Altaf M., Nourani A., Doyon Y., Utley R.T., Cronier D., Allard S., and Côté J. (2008). Eaf1 
is the Platform for NuA4 Molecular Assembly that Evolutionarily Links Chromatin Acetylation to ATP-Dependent 
Exchange of Histone H2A Variants. Mol Cell Biol. (28): 2257-2270. 
Balasubramanian R., Pray-Grant M.G., Selleck W., Grant P.A., and Tan S. (2002) Role of the Ada2 and Ada3 
Transcriptional Coactivators in Histone Acetylation. J Biol Chem. (277): 7989-7995. 
Barbet N.C., Schneider U., Helliwell S.B., Stansfield I., Tuite M.F., and Hall M.N. (1996) TOR Control Translation 
Initiation and Early G1 Progression in Yeast. Mol Biol Cell. (7): 25-42. 
Belotserkovskaya R., Sterner D.E., Deng M., Sayre M.H., Lieberman P.M. and Berger S.L. (2000) Inhibition of 
TATA-Binding Protein Function by SAGA Subunits Spt3 and Spt8 at Gcn4-Activated Promoters. Mol Cell Biol. 
(20): 634-647. 
Berndt A., Miller S., Williams O., Le D.D., Houseman B.T., Pacold J. I., Gorrec F., Hon W-C., Liu Y., Rommel C., 
Gaillard P., Rückle T., Schwarz M.K., Shokat K.M., Shaw J.P., and Williams R.L. (2010) The p110δStructure: 
Mechanisms for Selectivity and Potency of New PI(3)K Inhibitors. Nat Chem Biol. (6): 117-124. 
Bhaumik S.R. and Green M.R. (2002) Differential Requirement of SAGA Components for Recruitment of TATA-
Box-Binding Protein to Promoter in vivo. Mol Cell Biol. (22): 7365-7371. 
Bird A. W., Yu D.Y., Pray-Grant M.G., Qui Q., Harmon K.E., Megee P.C., Grant P.A., Smith M.M., and Christman 
M.F. (2002). Acetylation of histone H4 by Esa1 is Required for DNA Double-Strand Break Repair. Nature. (419): 
411-415. 
Bonnet J., Romier C., Tora L., and Devys D. (2008) Zinc-finger UBPs: Regulators of Deubiquitylation. Trends 
Biochem Sci. (33) 369-375. 
Bosotti R., Isacchi A., and Sonnhammer E.L.L. (2000) FAT: a Novel Domain in PIK-Related Kinases. Trends 
Biochem Sci. (25): 225-227. 
Boudreault A.A., Cronier D., Selleck W., Lacoste N., Utley R.T., Allard S., Savard J., Lane W.S., Tan S., and Côté 
J. (2003) Yeast Enhancer of Polycomb Defines Global Esa1-Dependent Acetylation of Chromatin. Genes Dev. (17): 
1415-1428. 
Brewerton S.C., Doré A.S., Drake A.C.B., Leuther K.K., and Blundell T.L. (2004) Structural Analysis of DNA-
PKcs: Modelling of the Repeat Units and Insights into the Detailed Molecular Architecture. J Struct Biol. (145): 
295-306. 
87 
 
Brown E.J. and Baltimore D. (2003) Essential and Dispensable Roles of ATR in Cell Cycle Arrest and Genome 
Maintenance. Genes Dev. (17): 615-628. 
Brown C. E., Howe L., Sousa K., Alley S.C. Carrozza M.J., Tan S., and Workman J.L. (2001). Recruitment of HAT 
Complexes by Direct Activator Interactions with the ATM-Related Tra1 Subunit. Science. (292): 2333-2337. 
Budillon A., Di Gennaro E., Bruzzese F., Rocco M., Manzo G., and Caraglia M. (2007) Histone Deacetylase 
Inhibitors: A New Wave of Molecular Targeted Anticancer Agents. Recent Pat Anti-Canc. (2): 119-134. 
Burtelow M.A., Roos-Mattjus P.M.K., Rauen M., Babendure J.R., and Karnitz L.M. (2001). Reconstitution and 
Molecular Analysis of the hRad9-hHus1-hRad1 (9-1-1) DNA Damage Responsive Checkpoint Complex. J. Biol 
Chem (276): 25903-25909. 
Chittuluru J.R., Chaban Y., Monnet-Saksouk J., Carrozza M.J., Sapountzi V., Selleck W., Huang J., Utley R.T., 
Cramet M., Allard S., Cai G., Workman J.L., Fried M.G., Tan S., Côté J., and Asturias F.J. (2011). Structure and 
Nucleosome Interaction of the Yeast NuA4 and Piccolo-NuA4 Histone Acetyltransferase Complexes. Nat Struct 
Mol Biol. (18): 1196-1204. 
Clapier C.R. and Cairns B.R. (2009). The Biology of Chromatin Remodeling Complexes. Annu Rev Biochem. (78): 
273-304. 
Clark D.J. and Felsenfeld G. (1992) A Nucleosome Core is Transferred out of the Path of a Transcribing 
Polymerase. Cell. (71): 11-22. 
Cortez D., Guntuku S., Qin J., and Elledge S.J. (2001) ATR and ATRIP: Partners in Checkpoint Signalling. Science. 
(294): 1713-1716. 
Dames S.A., Mulet J.M., Rathgeb-Szabo K., Hall M.N., and Grzesiek S. (2005) The Solution Structure of the FATC 
Domain of the Protein Kinase Target of Rapamycin Suggests a Role for Redox-dependent Structural and Cellular 
Stability. J Biol Chem. (280): 20558-20564. 
Dames S.A. (2009). Structural Basis for the Association of the Redox-sensitive Target of Rapamycin FATC Domain 
with Membrane-mimetic Micelles. J Biol Chem. (285): 7766-7775. 
Daniel J.A., Torok M.S., Sun Z-W., Schieltz D., Allis D., Yates III J.R., and Grant P.A. (2004) Deubiquitination of 
Histone H2B by a Yeast Acetyltransferase Complex Regulates Transcription. J Biol Chem. (279): 1867-1871. 
DaSilva L., Pillon S., Genereaux J., Davey M.J., Gloor G.B., Karagiannis J., and Brandl C.J. The Extreme C-
terminus of Saccharomyces cerevisiae Mec1 is Required for its Localization, Stability, and Function. Submitted to 
G3: Genes, Genomes, Genetics.  
Delacroix S., Wagner J.M., Kobayashi M., Yamamoto K., and Karnitz L.M. (2007). The Rad9-Hus1-Rad1 (9-1-1) 
Clamp Activated Checkpoint Signaling via TopBP1.Gene Dev. (21):1472-1477. 
Downs J.A., Allard S., Jobin-Robitaille O., Javaheri A., Auger A., Bouchard N., Kron S.J., Jackson S.P. and Côté J. 
(2004). Binding of Chromatin-Modifying Activities to Phosphorylated Histone H2A at DNA Damage Sites. Mol 
Cell. (16): 979-990. 
Doyon Y. And Côté J. (2004) The Highly Conserved and Multifunctional NuA4 HAT Complex. Curr Opin Genet 
Dev. (14): 147-154. 
88 
 
Dubrana K., van Attikum H., Hediger F., and Gasser S.M. (2007). The Processing of Double-Strand Breaks and 
Binding of Single-Strand-Binding Proteins RPA and Rad51 Modulate the Formation of ATR-Kinase Foci in Yeast. 
J Cell Sci. (120): 4209-4220. 
Dudley A.M., Gansheroff L.J., and Winston F. (1999a) Specific Components of the SAGA Complex are Required 
for Gcn4- and Gcr1-Mediated Activation of his4-912δPromoter in Saccharomyces cerevisiae. Genetics. (151): 1365-
1378. 
Edgar C.R. (2004). MUSCLE: Multiple Sequence Alignment with High Accuracy and High Throughput. Nucleic 
Acids Res. (32): 1792-1797. 
Eisenmann D.M., Arndt K.M, Ricupero S.L., Rooney J.W., and Winston F. (1992). SPT3 Interacts with TFIID to 
Allow Normal Transcription in Saccharomyces cerevisiae. Genes Dev. (6): 1319-1331. 
Eisenmann D.M., Chapon C., Roberts S.M., Dollard C., and Winston F. (1994) The Saccharomyces cerevisiae SPT8 
Gene Encodes a Very Acidic Protein that is Functionally Related to SPT3 and TATA-Binding Protein. Genetics 
(137): 647-657. 
Elsasser S. and Finley D. (2005) Delivery of Ubiquitinated Substrates to Protein-Unfolding Machines. Nature Cell 
Biol. (7): 742-749.  
Emili A. (1998). MEC1-Dependent Phosphorylation of Rad9p in Response to DNA Damage. Mol Cell. (2): 183-
189. 
Ewing B., Hillier L., Wendl M.C., and Green P. (1998) Base-Calling of Automated Sequencer Traces Using Phred. 
I. Accuracy Assessment. Genome Res. (8): 175-185. 
Ferdous, A., F. Gonzalez, L. Sun, T. Kodadek, and S. A. Johnston. (2001) The 19S regulatory particle of the 
proteasome is required for efficient transcription elongation by RNA polymerase II. Mol.Cell (7): 981-991. 
Fishburn J., Mohibullah N., and Hahn S. (2005) Function of a Eukaryotic Transcription Activator During the 
Transcription Cycle. Mol Cell. (18): 369-378. 
Flores O., Lu H., and Reinberg D. (1992) Factors Involved in Specific Transcription by Mammalian RNA 
Polymerase II. J Biol Chem. (267): 2786-2793.  
Friedel A.M., Pike B.L., and Gasser S.M. (2009). ATR/Mec1: Coordinating Fork Stability and Repair. Curr Opin 
Cell Biol. (21): 237-244. 
Genereaux J., Kvas S., Dobransky D., Karagiannis J., Gloor G.B., and Brandl C.J. (2012). Genetic Evidence Links 
the ASTRA Protein Chaperone Component Tti2 to the SAGA Transcription Factor Tra1. Genetics. (191): 765-780. 
Ghaemmaghami S., Huh W.K., Bower K., Howson R.W., Belle A., Dephoure N., O'Shea E.K., and Weissman J.S. 
(2003) Global Analysis of Protein Expression in Yeast. Nature. (425): 737-741 
Glickman M.H., Rubin D.M., Coux O., Wefes I., Pfeifer G., Cjeka Z., Baumeister W., Fried V.A., and Finley D. 
(1998) A Subcomplex of the Proteasome Regulatory Particle Required of Ubiquitin-Conjugate Degradation and 
Related to the COP9-Signalosome and eIF3. Cell. (94): 615-623. 
Glickman M.H., Rubin D.M., Fried V.A., and Finley D. (1998) The Regulatory Particle of the Saccharomyces 
cerevisiae Proteasome. Mol Cell Biol. (18): 3149-3162. 
89 
 
Gonzalez, F., A. Delahodde, T. Kodadek, and S. A. Johnston, 2002 Recruitment of a 19S proteasome subcomplex to 
an activated promoter. Science 296: 548-550. 
Govind C.K., Zhang F., Qui H., Hofmeyer K., and Hinnebusch A.G. (2007) Gcn5 Promotes Acetylation, Eviction, 
and Methlyation of Nucleosomes in Transcribed coding Regions. Mol Cell. (25): 31-42. 
Grant P.A., Schieltz D., Pray-Grant M.G., Steger D., Reese J.C., Yates III J.R., and Workman J.L. (1998a) A Subset 
of TAFIIs are Integral Components of the SAGA Complex Required for Nucleosome Acetylation and 
Transcriptional Stimulation. Cell. (94): 45-53. 
Grant P.A., Eberharter A., John S., Cook R.G., Turner B.M., and Workman J.L. (1999) Expanded Lysine 
Acetylation Specificity of Gcn5 in Native Complexes. J Biol Chem. (274): 5895-5900. 
Hampsey M. (1997) A Review of Phenotypes in Saccharomyces cerevisiae. Yeast. (13): 1099-1133. 
Helmlinger D., Marguerat S., Villén J., Swaney D.L., Gygi S.P., Bähler J., and Winston F. (2011) Tra1 has Specific 
Regulatory Roles, Rather than Global Functions, Within the SAGA Co-activator Complex. EMBO J. (0): 1-10. 
Helmlinger D. (2012) New Insights into the SAGA Complex from Studies of the Tra1 Subunit in Budding and 
Fission Yeast. Biochem Soc Symp. (3): 13-18. 
Henry K.W., Wyce A., Lo W-S., Duggan L.J., Emre N.C.T., Kao C-F., Pillus L., Shilatifard A., Osley M.A., and 
Berger S.L. (2003) Transcriptional Activation via Sequential Histone H2B Ubiquitylation and Deubiquitylation, 
Mediated by SAGA-Associated Ubp8. Genes Dev. (17): 2648-2663. 
Hercus C., 2013 www.novocraft.com(last accessed date June, 2013). 
Hirao A., Kong Y-Y., Matsuoka S., Wakeham A., Ruland J., Yoshida H., Liu D., Elledge S.J. and Mak T.W. (2000) 
DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2. Science. (287): 1824-1827. 
Hoke S.M.T., Guzzo J., Andrews B., and Brandl C.J. (2008) Systematic Genetic Array Analysis Links the 
Saccharomyces cerevisiae SAGA/SLIK and NuA4 Component Tra1 to Multiple Cellular Processes. BMC Genetics 
(9): 46-60. 
Hoke S.M.T, Mutiu A.I., Genereaux J., Kvas S., Buck M., Yu M., Gloor G.B., and Brandl C.J. (2010) Mutational 
Analysis of the C-terminal FATS Domain of Saccharomyces cerevisiae Tra1. Curr Genet. (56): 447-465. 
Holstege F.C.P., VanderVliet P.C., and Timmers H.T.M. (1996) Opening of a RNA Polymerase II Promoter Occurs 
in Two Distinct Steps and Requires the Basal Transcript Ion Factors IIE and IIH. EMBO J. (15): 1666-1677. 
Horiuchi J., Silverman N., Marcus G.A., and Guarente L. (1995) ADA3, a Putative Transcriptional Adaptor, 
Consists of Two Separable Domains and Interacts with ADA2 and GCN5 in a Trimeric Complex. Mol Cell. (15): 
1203-1209. 
Hoyt M.A., an Coffino P. (2004) Ubiquitin-Free Routes in the Proteasome. Cell Mol Life Sci. (61): 1596-1600. 
Huang M.X., Zhou Z., and Elledge S.J. (1998) The DNA Replication and Damage Checkpoint Pathways Induce 
Transcription by Inhibition of the Crt1 Repressor. Cell. (94): 595-605. 
Huang S., Bjornsti M-A., and Houghton P.J. (2003) Rapamycins: Mechanism of Action and Cellular Resistance. 
Cancer Biol Ther. (2): 222-232. 
90 
 
Hurov K.E., Cotta-Ramusino C., and Elledge S.J. (2010) A Genetic Screen Identifies the Triple T complex Required 
for DNA Damage Signaling and ATM and ATR Stability. Genes Dev. (24): 1939-1950. 
Jackson S.P. (1996) The Recognition of DNA Damage. Curr Opin Genet Dev. (6): 19-25. 
Jiang X., Sun Y., and Chen S. (2006) The FATC Domain of PIKK Proteins are Functionally Equivalent and 
Participate in the Tip60-Dependent Activation of DNA-PKcs and ATM. J Biol Chem. (281): 15741-15746. 
Kanemaki M., Kurokawa Y., Matsu-ura T., Makino Y., Masani A., Okazaki K., Morishita T., and Tamura T. (1999) 
TIP49b, a New Ruvb-like DNA Helicase, is Included in a Complex Together with Another RuvB-like DNA 
Helicase, TIP49a. J Biol Chem. (274):22437-22444. 
Kanoh J. and Yanagida M. (2007) Tel2: a Common Partner of PIK-Related Kinases and a Link Between DNA 
Checkpoint and Nutritional Response? Genes Cells. (12): 1301-1304. 
Keith C.T. and Schreiber S.L. (1995) PIK-Related Kinases: DNA Repair, Recombination and Cell Cycle 
Checkpoints. Science. (270): 50-51. 
Keogh M-C., Mennella T.A., Sawa C., Berthelet S., Krogan N.J., Wolek A., Podolny V., Carpenter L.R., Greenblatt 
J.F., Baetz K., and Buratowski S. (2006) The Saccharomyces cerevisiae Histone H2A Variant Htz1 is Acetylated by 
NuA4. Genes Dev. (20): 660-665. 
Khöler A., Pascual-García P., Llopis A., Zapater M., Posas F., Hurt E., and Rodríguez-Navarro S. (2006) The 
mRNA Export Factor Sus1 is Involved in Spt/Ada/Gcn5 Acetyltransferase-Mediated H2B Deubiquitinylation 
through its Interaction with Ubp8 and Sgf11. Mol Biol Cell. (17): 4228-4236. 
Khöler A., Schneider M., Cabal G.G., Nehrbass U., and Hurt E. (2008) Yeast Ataxin-7 Links Histone 
Deubiquitination with Gene Gating and mRNA Export. Nat Cell Biol. (10): 707-715. 
Killeen M., Coulombe B., and Greenblatt J. (1992) Recombinant TBP, Transcription Factor IIB, and RAP30 are 
Sufficient for Promoter Recognition by Mammalian RNA Polymerase II. J Biol Chem. (267): 9463-9466. 
Kim S.G., Hoffman G.R., Poulogiannis G., Buel G.R., Jang Y.J., Lee K.W., Kim B-Y., Erikson R.L., Cantley L.C., 
Choo A.Y., and Blenis J. (2013). Metabolic stress Controls mTORC1 Lysosomal Localization and Dimerization by 
Regulating the TTT-Ruvb1/2 Complex. Mol Cell. (49): 172-185. 
Knutson B.A. and Hahn S. (2011) Domains of Tra1 Important for Activator Recruitment and Transcription 
Coactivator Functions of SAGA and NuA4 Complexes. Mol Cell Biol. (31): 818-831. 
Kobor M.S., Venkatasubrahmanyam S., Meneghini M.D., Gin J.W., Jennings J.L., Link A.J., Madhani H.D., and 
Rine J. (2004). A Protein Complex Containing the Conserved Swi2/Snf2-Related ATPase Swr1p Deposits Histone 
Variant H2A.Z into Euchromatin. PLOS Biol. (2): 0587-0599. 
Langmead B, Trapnell C, Pop M, and Salzberg SL (2009) Ultrafast and Memory-Efficient Alignment of Short DNA 
Sequences to Human Genome. Genome Biol. 10(3):R25 
Lasker K., Förster F., Bohn S., Walzthoeni T., Villa E., Unverdorberf P., Beck F., Aebersold R., Sali A., and 
Baumeister. (2011). Molecular Architecture of the 26S Proteasome Holocomplex Determined by an Integrative 
Approach. PNAS. (109): 1380-1387. 
Lee K.K., Florens L., Swanson S.K., Washburn M.P., and Workman J.L. (2005) The Deubiquitylation Activity of 
Ubp8 is Dependent upon Sgf11 and its Association with the SAGA Complex. Mol Cell Biol. (25): 1173-1182. 
91 
 
Lempiäinen H. and Halazonetis T.D. (2009) Emerging Common themes in Regulation of PIKKs and PI3Ks. EMBO 
J. (28): 3067-3073. 
Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R., and 1000 
Genome Project Data Processing Subgroup. (2009) The Sequence Alignment/Map (SAM) Format and SAMtools. 
Bioinformatics (25): 2078-2079. 
Lopes M., Cotta-Ramusino C., Pellicioli A., Liberi G., Plevani P., Muzi-Falconi M., Newlon C.S., and Foiani M. 
(2001). The DNA Replication Checkpoint Response Stabilizes Stalled Replication Forks. Nature. (412): 557-561. 
Lu P.Y.T., Lévesque N., and Kobor M.S. (2009) NuA4 and SWR1-C: Two Chromatin-Modifying Complexes with 
Overlapping Functions and Components. Biochem Cell Biol. (87): 799-815. 
Luger K., Mäder A.W., Richmond R.K., Sargent D.F., and Richmond T.J. (1997). Crystal Structure of the 
Nucleosome Core Particle at 2.8Å Resolution. Nature. (389): 251-260. 
Majka J., Niedziela-Majka A., and Burgers P.M.J. (2006). The Checkpoint Clamp Activates Mec1 Kinase During 
Initiation of the DNA Damage Checkpoint. Mol Cell. (24): 891-901. 
Makino Y., Mimori T., Koike C., Kanemaki M., Kurokawa Y., Inoue S., Kishimoto T., and Tamura T. (1998) 
TIP49, Homologous to the Bacterial DNA Helicase RuvB, Acts as an Autoantigen in Human. Biochem Bioph Res 
Co. (245): 819-823. 
Matsuoka S., Ballif B.A., Smogorzewska A., McDonals III E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., 
Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., and Elledge S.J. (2007). ATM and ATR Substrates Analysis 
Reveals Extensive Protein Networks Responsive to DNA Damage. Science. (316): 1160-1166. 
Maxon M.E., Goodrich J.A., and Tjian R. (1994) Transcription Factor IIE Binds Preferentially to RNA Polymerase 
IIa and Recruits TFIIH: a Model for Promoter Clearance. Genes Dev. (8): 515-524. 
Mizzen C.A., Yang X-J., Kokubo T., Brownell J.E., Bannister A.J., Owen-Hughes T., Workman J.L., Wang L., 
Berger S.L., Kouzarides T., Nakatani Y., and Allis C.D. (1996) The TAFII250 Subunit of TFIID has Histone 
Acetyltransferase Activity. Cell (87): 1261-1270. 
Mordes D.A., Glick G.G., Zhao R., and Cortez D. (2008) TopBP1 Activates ATR Through ATRIP and a PIKK 
Regulatory Domain. Genes Dev. (22): 1478-1489. 
Morita T., Yamashita A., Kashima I., Ogata K., Ishiura S., and Ohno S. (2007). Distant N- and C-terminal Domains 
are Required for Intrinsic Kinase Activity of SMG-1, a critical component of Nonsense-mediated mRNA Decay. J 
Biol Chem. (282) 7799-7808. 
Morrison A.J., Kim J-A., Person M.D., Highland J., Xiao J., Wehr T.S., Hensley S., Bao Y., Shen J., Collins S.R., 
Weissman J.S., Delrow J., Krogan N.J., Haber J.E., and Shen X. (2007). Mec1/Tel1 Phosphorylation of the INO80 
Chromatin Remodeling Complex Influences DNA Damage Checkpoint Responses. Cell. (130): 499-511. 
Mutiu A.I., Hoke S.M.T., Genereaux J., Hannam C., MacKenzie K., Jobin-Robitaille O., Guzzo J., Côté J., Andrews 
B., Haniford D.B., and Brandl C.J. (2007) Structure/Function Analysis of the Phosphatidylinositol-3-Kinase Domain 
of Yeast Tra1. Genetics. (177): 151-166. 
Nakada D., Hirano Y., Tanaka Y., and Sugimoto K. (2005) Role of the C-terminus of Mec1Checkpoint Kinase in Its 
Localization to Sites of DNA Damage. Mol Biol Cell. (16): 5227-5235. 
92 
 
Noma K., Allis C.D., and Grewal S.I.S. (2001) Transitions in Distinct Histone H3 Methylation Patterns at the 
Heterochomatin Domain Boundaries. Science. (293): 1150-1155. 
Ozols J. (1990) Amino-Acid Analysis. Methods Enzymol. (182): 587-601. 
Perry J. and Kleckner N. (2003) The ATRs, ATMs, and TORs are Giant HEAT Repeat Proteins. Cell. (112): 151-
155. 
Pray-Grant M.G., Schieltz D., McMahon S.J., Wood J.M., Kennedy E.L., Cook R.G., Workman J.L., Yates III J.R., 
and Grant P.A. (2002) The Novel SLIK Histone Acetyltransferase Complex Functions in the Yeast Retrograde 
Response Pathway. Mol Cell Biol. (22): 8774-8786. 
Pray-Grant M.G., Daniel J.A., Schieltz D., Yates III J.R., and Grant P.A. (2005) Chd1 Chromodomain Links 
Histone H3 Methylation with the SAGA- and SLIK-dependent Acetylation. Nature. (433): 434-438. 
Qi J. and Zhao F. (2010) http://ingap.sourceforge.net/(last accessed date, June 2013) 
Ranish J.A., Yudkovsky N., and Hahn S. (1999) Intermediates in Formation and Activity of the RNA Polymerase II 
Preinitiation Complex: Holoenzyme Recruitment and a Postrecruitment Role for the TATA Box and TFIIB. Genes 
Dev. (13): 49-63. 
Rea S., Eisenhaber F., O’Carroll D., Strahl B.D., Sun Z-W., Schmid M., Opravil S., Mechtler K., Ponting C.P., Allis 
C.D., and Jenuwein T. (2000) Regulation of Chromatin Structure by Site-Specific Histone H3 Methyltransferase. 
Nature. (406): 593-599. 
Reinberg D. And Roeder R.G. (1987) Factors Involved in Specific Transcription by Mammalian RNA Polymerase 
II. J Biol Chem. (262): 3310-3321. 
Rigaut G., Shevchenko A., Rutz B., Wilm M., Mann M., and Séraphin B. (1999) A Generic Protein Purification 
Method for Protein Complex Characterization and Proteome Exploration. Nature Biotech (17): 1030-1032. 
Rivera-Calzada A., Maman J.P., Spagnolo L., Pearl L.H., and Llorca O. (2005). Three-Dimensional Structure and 
Regulation of the DNA-Dependent Protein Kinase Catalytic Subunit (DNA-PKcs). Structure. (13): 243-255. 
Robinson J.T., Thorvaldsdóttir H., Winckler W., Guttman M., Lander E.S., Getz G., and Mesirov J.P. (2011) 
Integrative Genomics Viewer. Nature Biotechnology (29): 24-26. 
Rodriguez-Navarro S. (2009). Insights into SAGA Function During Gene Expression. EMBO Rep. (10) 843-850. 
Rodriguez J. And Tsukiyama T. (2013). ATR-like kinase Mec1 Facilitates both Chromatin Accessibility at DNA 
Replication Forks and Replication Fork Progression During Replication Stress. Genes Dev. (27): 74-86. 
Ruediger R., Hentz M., Fait J., Mumby M., and Walter G., (1994). Molecular Model of the A Subunit of Protein 
Phosphatase 2A: Interaction with Other Subunits and Tumor Agents. J Virol. (68): 123-129. 
Saleh A., Lang V., Cook R., and Brandl C.J. (1997) Identification of Native Complexes Containing the Yeast 
Coactivator/Repressor Proteins NGG1/ADA3 and ADA2. J Biol Chem. (272) 5571-5578. 
Saleh A., Schieltz s., Ting N., McMahon S.B., Litchfield D.W., Yates III J.R., Lees-Miller S.P., Cole M.D., and 
Brandl C.J. (1998) Tra1p is a Component of the Yeast Ada∙Spt Transcriptional Regulatory Complexes. J Biol Chem. 
(273): 26559-26565. 
93 
 
Samara N.L. and Wolberger C. (2011) A New Chapter in the Transcription SAGA. Curr Opin Struct Biol.(21): 767-
774. 
Shen X., Mizuguchi G., Hamiche A., and Wu C. (2000) A Chromatin Remodeling Complex Involved in 
Transcription and DNA Processing. Nature. (406): 541-544 
Shevchenko A., Roguev A., Schaft D., Buchanan L., Habermann B., Sakalar C., Thomas H., Krogan NJ., 
Shevchenko A., and Stewart A.F. (2008). Chromatin Central: Towards the Comparative Proteome by Accurate 
Mapping of the Yeast Proteomic Environment. Genome Biol. (9): R167. 
Sibanda B.L., Chirgadze D.Y., and Blundell T.L. (2010). Crystal Structure of DNA-PKcs Reveals a Large Open-
Ring Cradle Comprised of HEAT Repeats. Nature. (463): 118-122. 
Sommer L.A.M., Schaad M., and Dames S.A. (2013) NMR-and CD-Monitored Lipid-Binding Studies Suggest a 
General Role for the FATC Domain as Membrane Anchor of Phosphatidyl-Inositol-3 Kinase-Related Kinases 
(PIKKs). J Biol Chem. (288): 20046-20063. 
Sorokin A.V., Kim E.R., and Ovchinnikov L.P. (2009) Proteasome System of Protein Degradation and Processing. 
Biochemistry-Moscow+. (74): 1411-1442. 
Stirling P.C., Bloom M.S., Solanki-Patil T., Smith S., Sipahimalani P., Li z., Kofoed M., Ben-Aroya S., Myung K., 
and Hieter P. (2011). The Complex Spectrum of Yeast Chromosome Instability Genes Identifies Candidate CIN 
Cancer Genes and Functional Roles for ASTRA Complex Components. PLOS Genet. (7): 1-10. 
Strahl B.D. and Allis C.D. (2000). The Language of Covalent Histone Modifications. Nature (403): 41-45. 
Steinboeck F., Bogusch A., Kaufmann A., and Heidenreich E. (2007). The Nuclear Actin-Related Protein of 
Saccharomyces cerevisiae, Arp4, Directly Interacts with the Histone Acetyltransferase Esa1p. J Biochem.(141): 
661-668. 
Takahashi T., Hara K., Inoue H., Kawa Y., Tokunaga C., Hidayat S., Yoshino K., Kuroda Y., and Yonezawa K. 
(2000). Carboxyl-terminal Region Conserved Among Phosphoinositide-Kinase-Related Kinases is Indispensable for 
mTOR Function in vivo and in vitro. Genes Cell. (5): 765-775. 
Takai H., Xie Y., de Lange T., and Pavletich N.P. (2010) Tel2 Structure and Function in the Hsp90-dependent 
Maturation of mTOR and ATR Complexes. Genes Dev. (24): 2019-2030. 
Tatebayashi K., Tanaka K., Yang H-Y., Yamamoto K., Matsushita Y., Tomida T., Imai M., and Saito H. (2007). 
Transmembrane Mucins Hkr1 and Msb2 are putative osmosensors in the SHO1 branch of yeast HOG pathway. 
EMBO J. (26): 3521-3533. 
Tseng S-F., Lin J-J., and Teng S-C. (2006). The Telomerase-Recruitment Domain of the Telomere Binding Protein 
Cdc13 is Regulated by Mec1p/Tel1p-Dependent Phosphorylation. Nucleic Acids Res.(34): 6327-6336. 
Wandelt C. and Grummt I. (1983) Formation of Stable Preinitiation Complexes is Prerequisite for Ribosomal DNA 
Transcription in vitro. Nucleic Acids Res. (11): 3795-3809. 
Weinert T.A., Kiser G.L., and Hartwell L.H. (1994) Mitotic Checkpoint Genes in Budding Yeast and the 
Dependence of Mitosis on DNA Replication and Repair. Genes Dev. (8): 652-665. 
Wu P-Y. J. and Winston F. (2002) Analysis of Spt7 Function in the Saccharomyces cerevisiae SAGA Coactivator 
Complex. Mol Cell Biol. (22): 5367-5379. 
94 
 
Yamashita A., Ohnishi T., Kashima I., Taya Y., and Ohno S. (2001) Human SMG-1, a Novel Phosphatidylinositol 
3-Kinase-Related Protein Kinase, Associates with Components of the mRNA Surveillance Complex and is Involved 
in the Regulation of Nonsense-Mediated mRNA Decay. Genes Dev. (15): 2215-2228. 
Yang H., Rudge D.G., Koos J.D., Vaidialingam B., Yang H.J., and Pavletich N.P. (2013) mTOR Kinase Structure, 
Mechanism and Regulation. Nature. (497): 217-224. 
Zhao X., Muller E.G.D., Rothstein R. (1998) A Suppressor of Two Essential Checkpoint Genes Identifies a Novel 
Protein that Negatively Affects dNTP Pools. Mol Cell. (2): 329-340. 
Zou L. And Elledge S.J. (2003). Sensing DNA Damage through ATRIP Recognition of RPA-ssDNA Complexes. 
Science. (300): 1542-1548. 
 
 
  
95 
 
Supplemental Data 
######################################## 
# ARRAY DATA FOR MEC SUPPRESSORS # 
######################################## 
#declare 10 elements for three different arrays that will be applied to the SAMPLE and NAME variables 
ARRAYNAMES=( MEC8182 A2 A3 A4 B1 B2 B3 C2 C3 C6 ) 
ARRAYBARCODES=( CCAACA CATTTT CAAAAG CACGAT ATTCCT ATGAGC CAGGCG CACTCA 
CGGAAT ACTGAT ) 
ARRAYNUMBER=( '002' '002' '001' '002' '001' '002' '002' '002' '002' '002' ) 
# get number of elements in the array 
ELEMENTS=${#ARRAYNAMES[@]} 
# echo each element in array  
# for loop 
for (( i=0;i<$ELEMENTS;i++)); do 
#due to the {i} within the variables, they must be within the for loop since the for loop denotes the {i} 
#assign variables to array so when the loop runs it will go through all the elements in the array. 
SAMPLE=Sample_${ARRAYNAMES[${i}]}/${ARRAYNAMES[${i}]}_${ARRAYBARCODES[${i}]}_L006_R1
_${ARRAYNUMBER[${i}]}.fastq 
NAME=${ARRAYNAMES[${i}]} 
#script used to run the mapping program  
if [ -e $DATA/$NAME/map_best3_$NAME.sam ]; then 
echo "$DATA/$NAME/map_best3_$NAME.sam file exists" 
else  
#gunzip $DATA/$SAMPLE.gz 
if [ -e $DATA/$SAMPLE ]; then 
#if the file is unzipped, run through program 
#make new directory to store the mapped data file 
mkdir $DATA/$NAME 
bowtie -S -v 3 -t $DATA/$IDX -q $DATA/$SAMPLE $DATA/$NAME/map_best3_$NAME.sam 
else  
#if not unzipped, the file will be unzipped before going through the mapping program 
gunzip $DATA/$SAMPLE.gz 
mkdir $DATA/$NAME 
bowtie -S -v 3 -t $DATA/$IDX -q $DATA/$SAMPLE $DATA/$NAME/map_best3_$NAME.sam 
fi 
fi 
#make sure that this portion of the script is out of the previous "if" statement 
#if it is not, it will go through the frist statement, noting the file exists and stop 
#when it is out of that statement, it will continue on to make a bam file if the file already exists  
#or if not, it will do the mapping then convert to bam 
#converting to BAM - same strategy as with mapping 
#if sorted BAM file exists, echo filename 
#if not then sort it using samtools function 
if [ -e $DATA/$NAME/map_best3_$NAME.bam ]; then 
echo "$DATA/$NAME/map_best3_$NAME.bam file exists" 
else 
echo "making map_best3_$NAME.bam file" 
samtools view -bS $DATA/$NAME/map_best3_$NAME.sam > $DATA/$NAME/map_best3_$NAME.bam 
fi 
#sort the bam files and index to be able to do a pileup 
#the pileup will group the variants so that they can be analyzed through a variant filter to get a Phred 
score 
#Phred score tells us the certainty of the variant 
if [ -e $DATA/$NAME/bamsorted_$NAME.bam ]; then 
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echo "$DATA/$NAME/raw_pileup_$NAME.txt file exists" 
else 
echo "making $DATA/$NAME/raw_pileup_$NAME.txt" 
#sort the bam files 
#samtools sort <in> <out> 
#don't need to end the new sorted filename with .bam since it will be added automatically 
samtools sort $DATA/$NAME/map_best3_$NAME.bam $DATA/$NAME/bamsorted_$NAME 
#index the bam files 
samtools index $DATA/$NAME/bamsorted_$NAME.bam 
#run the pileup of the variants 
#vcf is for variant call format 
samtools pileup -vcf $YEAST/yeast.fsa $DATA/$NAME/bamsorted_$NAME.bam > 
$DATA/$NAME/raw_pileup_$NAME.txt 
fi 
#to filter through variants and keep those with a Phred quality score of 20 or more 
if [ -e $DATA/$NAME/filtered_pileup_$NAME.txt]; then 
echo "$DATA/$NAME/filtered_pileup_$NAME.txt file exists" 
else 
echo "making $DATA/$NAME/filtered_pileup_$NAME.txt" 
#create new file of all the filtered variants 
samtools.pl varFilter $DATA/$NAME/raw_pileup_$NAME.txt | awk '$6>=20' > 
$DATA/$NAME/filtered_pileup_$NAME.txt 
fi 
done 
Figure S1: Shell script to map the Illumina dataset to S. cerevisiae reference genome. The 
Bowtie software was used to map the Illumina reads to the reference genome obtained from 
SGD. SNPs were identified by the program and a table of variants was created using SAMtools. 
Phred scores above 20 were isolated and saved in a new file: filtered_pileup_$NAME.txt . This 
script (bc_supp.sh) was written by Dr. Greg Gloor and Stephanie Kvas, modified by Samantha 
Pillon. 
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#!/usr/bin/env perl -w 
use strict; 
my $variants = $ARGV[0]; #pilup output 
my $ft = $ARGV[1]; #YAR066W NC_001133 221049 221660 Yar066wp 
#build an index of all positions inside genes 
my %feat; 
open (IN, "< $ft") or die; 
while(my $l = <IN>){ 
chomp $l; 
my @l = split/\t/, $l; 
if ($l[3]){ 
my $mx = $l[2]; $mx = $l[3] if $l[3] > $l[2]; 
my $mn = $l[2]; $mn = $l[3] if $l[3] < $l[2]; 
for (my $i = $mn; $i < $mx; $i++){ 
$feat{$l[1]}{$i} = $l[0]; 
} 
} 
} 
close IN; 
my %var; 
open (IN, "< $variants") or die; 
while(my $l = <IN>){ 
chomp $l; 
my @l = split/[\t\|]+/, $l; 
if (exists $feat{$l[1]}{$l[2]}){ 
print "$feat{$l[1]}{$l[2]}\t$l\n"; 
}else{ 
print "extragenic\t$l\n"; 
} 
} 
close IN; 
Figure S2: Perl script to assign gene names to each SNP. This script (parse_yeast.pl) was 
written by Dr. Greg Gloor. 
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#!/usr/bin/env perl -w 
use strict; #enforces good programing practices 
use warnings; 
=com 
This program literally compares two files and makes a third file containing the differences between the 
two files. 
This program will be used to compare the polymorphisms between wild-type whole-genome sequencing 
data and the  
suppressors. Therefore, this will be used to narrow down the number of suppressor mutations.  
=cut 
my $filename = $ARGV[0]; #specify wild-type file to compare to 
my $filename2 = $ARGV[1]; #specify second file to compare to 
my %results = (); 
print "enter wild type first, then mutant\noutput by command redirection\n" if !$ARGV[0]; 
exit if !$ARGV[0]; 
open FILE1, "$filename" or die "Could not open file: $! \n"; 
while(my $line = <FILE1>){ 
chomp $line; 
my @l = split/\t/, $line; 
my $var = join ("", @l[0 .. 3]); #generate a unique name 
$results{$var} = $line; 
} 
close(FILE1); 
print "in mut, not wt\n"; 
open FILE2, "$filename2" or die "Could not open file: $! \n"; 
while(my $line =<FILE2>) { 
chomp $line; 
my @l = split/\t/, $line; 
my $var = join ("", @l[0 .. 3]); #generate a unique name 
print "$line\n" if (!exists $results{$var} && $l[3] =~ /[ACGT]/); 
} 
close(FILE2); 
%results = (); 
exit if !$ARGV[0]; 
open FILE1, "$filename2" or die "Could not open file: $! \n"; 
while(my $line = <FILE1>){ 
chomp $line; 
my @l = split/\t/, $line; 
my $var = join ("", @l[0 .. 3]); #generate a unique name 
$results{$var} = $line; 
} 
close(FILE1); 
print "in wt, not mut\n"; 
open FILE2, "$filename" or die "Could not open file: $! \n"; 
while(my $line =<FILE2>) { 
chomp $line; 
my @l = split/\t/, $line; 
my $var = join ("", @l[0 .. 3]); #generate a unique name 
print "$line\n" if (!exists $results{$var} && $l[3] =~ /[ACGT]/); 
} 
close(FILE2); 
Figure S3: Perl script to eliminate variants found in wildtype control sample. This script 
(Final_Comparisons.pl) was written by Stephanie Kvas and modified by Samantha Pillon.  
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#!/usr/bin/env perl -w 
use strict; 
# Need to realign A2 supp (RPN3) to check for indels 
# used novoalign which can be accessed from Greg's folders through the path 
# /Users/ggloor/bin/novoalign 
####### Indexing 
# First must make an index that can be used by novoalign 
# basic format from novoalign manual 
# novoindex indexfile.nix sequencefiletouseasreference.fsa 
/Users/ggloor/bin/novoindex /Users/spillon3/Project_ChrisB/data/Novoalign_Data/index.nix 
/Users/spillon3/yeast.fsa 
# Once index is made can then start aligning sequences 
######## Aligning Sequences 
# must follow illumina formating 
# in manual, tells to follow 
# novoalign -d indexfile.nix -f sequencefile.fastq 
# -d is the database name -f is the file name 
# can save file in SAM format by adding 
# -o SAM > alignments.sam 
# this makes the full line read as 
# novoalign -d indexfile.nix -f sequencefile.fastq -o SAM > alignments.sam 
# novoalign command line for A2 supp sample 
~/Downloads/novocraft/novoalign -d ~/Project_ChrisB/data/Novoalign_Data/index.nix-f 
~/Project_ChrisB/data/Sample_A2/A2_CATTTT_L006_R1_002.fastq -o SAM > 
~/Project_ChrisB/data/Novoalign_Data/A2alignment.sam 
# run sam file through inGAP program to visualise the indels. 
# need to also run WT/control sample to help filter out indels 
# to open inGAP 
java -mx2000m -jar inGAP_3_0_1/inGAP.jar  
Figure S4: Perl script for Novoalign sequence alignment to check for indels in rpn3 
suppressor sample. The rpn3 suppressor sample datum aligned with Novoalign and then the 
indels present are viewed using inGAP. This script (novoalign.pl) was written by Samantha 
Pillon. 
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Table S1: S. cerevisiae Strains 
  Strain 
Number 
Description Plasmids Reference 
BY4743 
MAT a/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 lys2Δ0/LYS2 
MET15/met15Δ0 ura3Δ0/ura3Δ0 
  Winzeler et al., 1997 
CY4398  
MAT a/α HIS3/his3Δ1 leu2Δ0/leu2Δ0 
MET15/MET15 URA3/ura3Δ0 TRA1/TRA1  
Genereaux et al., 2012 
CY4353 MAT a his3Δ1ura3Δ0 leu2Δ0 TRA1-HIS3  
 
Hoke et al., 2010 
CY6070 MAT a ura3Δ0 LEU2 LYS2 tti2Δ CB2319 This work 
CY6145 Isogenic to CY6070 CB2494 This work 
CY6497 
Isogenic to CY4398 with FLAG5 tagged tra1-
F3744S allele  
This work 
CY6499 MAT α HIS3 leu2Δ0 MET15 ura3Δ0 tra1-F3744S CB2331 This work 
CY6514 
Isogenic to CY4398 with untagged tra1-F3744R 
allele  
This work 
CY6507 
Isogenic to CY4398 with FLAG5 tagged tra1-WF-
FW allele  
This work 
 CY6503 MAT α HIS3 leu2Δ0 MET15 URA3 tra1-WF-FW CB1932 This work 
CY6504  MAT α HIS3 leu2Δ0 MET15 ura3Δ0 tra1-WF-FW CB2331 This work 
CY6508 
Isogenic to CY4398 with FLAG5 tagged tra1-Δ1 
allele  
This work 
CY6509 
Isogenic to CY4398 with FLAG5 tagged tra1-Δ2 
allele  
This work 
CY6513 Isogenic to CY6070 CB2327 This work 
CY4118 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 TEL2-TAP 
fusion   
Ghaemmaghami et al., 2003 
CY4119 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 TTI1-TAP 
fusion   
Ghaemmaghami et al., 2003 
CY4419 
Isogenic to BY4743 except TRA1/URA3-Flag5-
TRA1-HIS3  
Genereaux et al., 2012 
CY4421 
Isogenic to BY4743 except TRA1/URA3-Flag5-tra1-
F3744A-HIS3  
Genereaux et al., 2012 
CY6076 MATa ura3∆0 his3∆0 leu2∆0 mec1-W2368A-HIS3 
 
Genereaux et al., 2012 
CY6267 
Isogenic with CY6076 except contain suppressor of 
Mec1-W2368A 
  DaSilva, In Press 
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Table S2: Oligonucleotides used in this study 
 Name Sequence (5’-3’) Description 
4225-7 GCATTAATTGAAGCTGATAATGAAGAACTGAAC Forward primer used to 
amplify and sequence tra1 C-
terminus 
4479-1 ATACGAGCTCTTTGAGGCTTTCTCTACCTTC Reverse primer used to 
amplify and sequence tra1 C-
terminus 
6173-1 GACGTTATACGCATTGGAATG Forward primer to generate 
tti2-290-421 mutation 
6173-2 ACAGTTCTCTAGTACTGGTTTA Forward primer to generate 
tti2-206-421 mutation 
6173-3 ACCCACGCTTGGAATGTCTT Forward primer to generate 
tti2-116-421 mutation 
6223-1 AATATGCCGCTCACTCCATATCTCCAGGAG Forward primer to generate 
tti2-53-421 and tti2-53-238 
mutations 
6312-1 ATACGAGCTCTCAGGCTATTGTTTCATCAGCATTG Reverse primer to generate 
tti2-53-238 mutation 
5693-2 ATACGAGCTCTGCATTTGTCTGTGTCTGTGT Reverse primer to generate 
tti2  
4249-3 GCGGCCGCAAACGCAGCGCATGATGATG Forward primer to generate 
tra1  
6238-1 CATGCCATGGTCCTAGAGCTGATACATGGGT Forward primer to generate 
tra1-F3744S mutation 
6238-2 CATGCCATGGAGATAGAGCTGATACATGGGT Forward primer to generate 
tra1-F3744R mutation 
6241-1 ATTCCATGGCTACCAGAATGGCATGAAGTTCACGT 
CTG 
Reverse primer to generate 
tra1-WF-FW  
5747-1 CCCGAGCTCTTGATTGTTAGCAATACCG Reverse primer to generate 
tra1  
6260-1 CATGCCATGGTAGAGCTGATACATGGGTTAG Forward primer to generate 
tra1-Δ1  
6260-2 ATTCCATGGCTATGGCATGAAGTTCACGTCTG Reverse primer to generate 
tra1-Δ2  
6529-1 GTAGTACCTTCTGCCTATGC Forward primer to check hkr1 
for suppressor mutation 
6529-2 GGCAGCAAAAGTTGATGGAG Reverse primer to check hkr1 
for suppressor mutation 
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Table S3: DNA constructs used in this study 
Name Description 
CB2321 LEU2 centromeric plasmid containing the tti2-1-238 (myc tagged) gene without 
the URA3 marker  
CB2320 LEU2 centromeric plasmid containing the tti2-1-165 (myc tagged) gene without 
the URA3 marker  
CB2134 LEU2 centromeric plasmid containing TTI2 (myc tagged) gene used to make tti2 
truncations  
CB2327 LEU2 centromeric plasmid containing TTI2 (myc tagged) gene without the URA3 
marker  
CB1932 LEU2 centromeric plasmid containing the GEP4 gene  
CB2331 LEU2 centromeric plasmid containing the GEP4 and tti2-F328S genes  
CB2115 Parent plasmid of CB2134 used in the cloning of tti2 truncations 
pGEM T-Easy Vector used for cloning tti2 and tra1 mutations (Promega) 
CB2147 TRA1 template used to make tra1 substitution and deletion mutations  
CB2151 tra1FA template used to make tra1 substitution and deletion mutations  
CB2319 TTI2 tagged with URA3 gene on a plasmid; to use for plasmid shuffling assay  
CB2485 LEU2 centromeric plasmid containing the tra1-F3744S gene (with HIS3)  
CB2486 LEU2 centromeric plasmid containing the tra1-F3744R gene (with HIS3) 
CB2487 LEU2 centromeric plasmid containing the tra1-WF-FW gene (with HIS3) 
CB2488 LEU2 centromeric plasmid containing the tra1-Δ1 gene (with HIS3) 
CB2489 LEU2 centromeric plasmid containing the tra1-Δ2 gene (with HIS3) 
CB2490 LEU2 centromeric plasmid containing the tti2-Δ108-216 (myc tagged) gene 
without the URA3 marker  
CB2491 LEU2 centromeric plasmid containing the tti2-290-421 (myc tagged) gene without 
the URA3 marker  
CB2492 LEU2 centromeric plasmid containing the tti2-206-421 (myc tagged) gene without 
the URA3 marker  
CB2493 LEU2 centromeric plasmid containing the tti2-116-421 (myc tagged) gene without 
the URA3 marker  
CB2494 LEU2 centromeric plasmid containing the tti2-53-421 (myc tagged) gene without 
the URA3 marker  
CB2495 LEU2 centromeric plasmid containing the tti2-53-238 (myc tagged) gene without 
the URA3 marker  
103 
 
Curriculum Vitae 
Samantha A. Pillon 
 
Education: 
Master of Science (Biochemistry) 
The University of Western Ontario, London Ontario August 2013 
Bachelor of Medical Science (Honours Specialization – Biochemistry) 
The University of Western Ontario, London Ontario May 2011 
 
Honours/Awards 
Western Graduate Research Scholarship (WGRS) September 2011-August 2013 
 
Related Work Experience 
Teaching Assistant (Biochemistry 3380) 
The University of Western Ontario, London Ontario January 2012-April 2013 
Honours Thesis Student 
The University of Western Ontario, London Ontario September 2010-April 2011 
Summer Student 
The University of Western Ontario, London Ontario May 2010-August 2010 
 
Publications 
DaSilva, LF., Pillon, S.*, Genereaux, J., Davey, MJ., Gloor, GB., Karagiannis, J., and Brandl, 
CJ. The Extreme C-terminus of Saccharomyces cerevisiae Mec1 is required for its Localization, 
Stability and Function. In press. 
 
